0001420720false00014207202023-09-152023-09-15

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): September 15, 2023

iBio, Inc.

(Exact name of registrant as specified in charter)

Delaware

(State or other jurisdiction of incorporation)

001-35023

26-2797813

(Commission File Number)

(IRS Employer Identification No.)

8800 HSC Parkway

Bryan, Texas 77807

(Address of principal executive offices and zip code)

(979) 446-0027

(Registrant’s telephone number including area code)

N/A

(Former Name and Former Address)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

   Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)

   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001 par value per share

IBIO

NYSE American

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 1.01. Entry Into a Material Definitive Agreement.

Purchase and Sale Agreement

On September 15, 2023, iBio CDMO LLC (“iBio CDMO”), a subsidiary of iBio, Inc. (the “Company”), entered into a purchase and sale agreement, dated as of September 15, 2023 (the “Purchase and Sale Agreement”) with Majestic Realty Co., a California corporation (“Majestic Realty”), pursuant to which iBio CDMO agreed to sell to Majestic Realty its cGMP biologics manufacturing facility located in Bryan, TX consisting of: (i) the ground leasehold estate and interest held under the Ground Lease Agreement, dated March 8, 2010, as amended by an Estoppel Certificate and Amendment to Ground Lease Agreement, dated as of December 22, 2015, between iBio CDMO (as assignee from College Station Investors LLC) and The Board of Regents of the Texas A&M University System (together, the “Ground Lease”), related to 21.401 acres in Brazos County, Texas land (the “Land”); (ii) the buildings, parking areas, improvements, and fixtures situated on the Land (the “Improvements”); (iii) all iBio CDMO’s right, title, and interest in and to furniture, personal property, machinery, apparatus, and equipment owned and currently used in the operation, repair and maintenance of the Land and Improvements and situated thereon (collectively, the “Personal Property”); (iv) all iBio CDMO’s rights under the contracts and agreements relating to the operation or maintenance of the Land, Improvements or Personal Property which extend beyond the closing date (the “Contracts”); and (v) all iBio CDMO’s rights in intangible assets of any nature relating to any or all of the Land, the Improvements and the Personal Property (the “Intangibles”; and together with the Ground Lease, Improvements and Personal Property, collectively, the “Property”).

The Purchase and Sale Agreement provides that the Property will be sold to Majestic Realty for a purchase price of $17,250,000 (the “Purchase Price”). The closing of the sale of the Property is to occur, with time being of the essence, on December 1, 2023, or such other date as mutually agreed.  Pursuant to the terms of the Purchase and Sale Agreement, Majestic Realty deposited with a title company (the “Escrow Agent”) $200,000 as an earnest money deposit. Majestic Realty will also be afforded access to the Property to conduct a due diligence review of its condition.

The closing is subject to certain closing conditions, including: (i) Majestic Realty’s delivery to iBio CDMO and the Escrow Agent of written notice of its approval of the condition of the Property (the “Property Approval Notice”) on or before 5:00 p.m. Central time on October 16, 2023 (the “Due Diligence Deadline”); (ii) Majestic Realty obtaining the approval of The Board of Regents of the Texas A&M University System of Majestic Realty’s purchase from it of the fee interest in the Land (the “TAMU Approval”) on or before 5:00 p.m. Central time on November 13, 2023 (the “TAMU Approval Deadline”); and (iii) the delivery at closing by the title company of a title policy to Majestic Realty in the amount of the Purchase Price.

There can be no assurance that the closing conditions for the sale of the Property will be satisfied. If the Property Approval Notice is not given prior to the Due Diligence Deadline or Majestic Realty is unable to obtain the TAMU Approval by the TAMU Approval Deadline, Majestic Realty will be deemed to have elected to terminate the Purchase and Sale Agreement.

Attached hereto as Exhibit 99.1, and incorporated herein by reference, is unaudited pro forma financial information of the Company as of March 31, 2023 and for the nine-month period ended March 31, 2023, and the year ended June 30, 2022, giving effect to the disposition of the Property.

Sixth Amendment to Credit Agreement

On September 18, 2023, iBio CDMO and Woodforest National Bank entered into the Sixth Amendment (the “Sixth Amendment”) to that certain Credit Agreement, dated November 1, 2021, as previously amended as of October 11, 2022, February 9, 2023, February 20, 2023, March 24, 2023 and May 10, 2023 (the “Credit Agreement”), to amend the Credit Agreement to: (i) set the maturity date of the term loan to the earlier of (a) December 31, 2023, or (b) the acceleration of maturity of the term loan in accordance with the Credit Agreement, (ii) provide that iBio CDMO will, immediately upon receipt of the proceeds of the sale of the Property, apply the net proceeds to satisfy all outstanding obligations under the term loan, and to the extent such net proceeds are sufficient, to pay off the term loan, and (iii) change the annual filing requirement solely for the fiscal year ending June 30, 2023, such that the filing is acceptable with or without a “going concern” designation; provided that (a) iBio CDMO shall deliver an executed copy of the Purchase and Sale Agreement for the sale of the Facility within one business day after entry into the Sixth Amendment, and (b) if the Facility is not sold on or before December 1, 2023, iBio CDMO will pay a fee in the amount of $20,000 upon the earlier of the date of the closing or the maturity date.  

The foregoing descriptions of the Purchase and Sale Agreement and Sixth Amendment to the Credit Agreement are qualified in their entirety by reference to the full text of such agreements, copies of which are attached hereto as Exhibits 10.1 and 10.2, respectively, and each of which is incorporated herein in its entirety by reference. The representations, warranties and covenants contained in such agreements were made only for purposes of such agreements and as of specific dates, were solely for the benefit of the parties to such agreements and may be subject to limitations agreed upon by the contracting parties.

Item 2.02 Results of operations and financial condition

The Company’s audited consolidated financial statements for the twelve months ending June 30, 2023, are not yet available. The Company’s expectations with respect to our audited results for the period discussed below are based upon management estimates. The estimates set forth below were prepared based upon a number of assumptions, estimates and business decisions that are inherently subject to significant business and economic conditions and competitive uncertainties and contingencies, many of which are beyond the Company’s control. This summary is not meant to be a comprehensive statement of the Company’s unaudited financial results for this period and, although we do not expect actual result to differ materially from the preliminary estimates discussed below, our actual results may differ from these estimates.

On a preliminary unaudited basis, the Company expects net loss from continuing operations for the twelve months ending June 30, 2023, to be between $29.0 million and $29.5 million, as compared to a net loss from continuing operations of $29.6 million for the prior twelve months ending June 30, 2022, which included approximately $1.9 million of revenue mainly related to license income resulting from the settlement of litigation. Cash at June 30, 2023 was approximately $7.6 million, including approximately $3.3 million of restricted cash as compared to $28.7 million, including $6 million of restricted cash at June 30, 2022. The term note principal balance was approximately $13.1 million and $22.4 million at June 30, 2023 and 2022, respectively. There were approximately 20.3 million of common shares outstanding at June 30, 2023 as compared to 8.7 million of common shares outstanding at June 30, 2022.

The estimates of net loss from continuing operations, cash, the note payable and outstanding shares are the Company’s preliminary estimates based on currently available information and they do not present all necessary information for an understanding of our financial condition as of June 30, 2023, or our results of operations for the twelve months ended June 30, 2022.

As the Company completes the process of its year-end financial close unaudited financial statements, it will be required to make significant judgments in a number of areas that may result in the estimates provided herein being different than the final financial information. The preliminary estimates have been prepared by and are the responsibility of our management.

The Company’s independent registered public accounting firm has not audited, reviewed or performed any procedures with respect to the preliminary estimates or the accounting treatment thereof and does not express an opinion or any other form of assurance with respect thereto. The Company expects to complete our audited financial statements for the year ended June 30, 2023, and to file the related Annual Report on Form 10-K in a timely fashion. It is possible that the Company or its independent registered public accounting firm may identify items that require it to make adjustments to the preliminary estimates of net loss from continuing operations, cash, note payable and common shares outstanding set forth above and those changes could be material. The preliminary estimates are not necessarily indicative of any future period and should be read together with the sections titled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended June 30, 2022, and its subsequent filings with the U.S. Securities and Exchange Commission, including subsequent periodic reports on Forms 10-Q and 8-K.

Item 8.01 Other Information.

The following risk factors are provided to supplement the risk factors of the Company previously disclosed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended June 30, 2022 and the Company’s Quarterly Reports on Form 10-Q for the quarters ended September 30, 2022, December 31, 2022 and March 31, 2023.

Risks Related to the Purchase and Sale Agreement

There can be no assurance that the sale of the Property will be completed in a timely manner or at all. If the sale is not completed by December 31, 2023, it is unlikely iBio CDMO would have sufficient funding to pay the Term Loan with Woodforest for which we are a guarantor.

Although iBio CDMO has entered into a Purchase and Sale Agreement for the sale of the Property, there can be no assurance that the sale of the Property will be completed in a timely manner or at all. The closing of the sale is subject to several material conditions including: (i) Majestic Realty’s delivery to iBio CDMO and the Escrow Agent of written notice of its approval of the condition of the Property on or before 5:00 p.m. Central time on October 16, 2023; (ii) Majestic Realty obtaining the approval of The Board of Regents of the Texas A&M University System of Majestic Realty’s purchase from it of the fee interest in the Land on or before 5:00 p.m. Central time on November 13, 2023; and (iii) the delivery at closing by the title company of a title policy to Majestic Realty in the amount of the purchase price.  None of the mentioned closing conditions are within our control.  

We cannot guarantee that these conditions will be satisfied. The conditions to the closing of the sale of the Property may not be fulfilled in a timely manner or at all, and, accordingly, the sale may not be completed. If the closing is not consummated prior to the December 31, 2023 maturity date of the Term Loan it is unlikely that we will have sufficient funds the repay the Term Loan on its maturity date, the outstanding balance of which is $12,688,817.05 as of September 15, 2023. The Company’s failure to make such payments when due could result in its loss of the Facility. Any action to proceed against the Company’s assets would likely have a serious disruptive effect on its business operations, especially if the Facility or its other assets were foreclosed upon or its guarantee were enforced.

Failure to complete the sale of the Property could negatively impact the stock price and the future business and financial results of the Company.

Majestic Realty’s obligations to complete the sale of the Property is subject to the satisfaction or waiver of a number of conditions set forth in the Purchase and Sale Agreement. There can be no assurance that the conditions to the completion of the sale will be satisfied or waived or that the sale will be completed. If the sale is not completed for any reason, the ongoing business of the Company may be materially and adversely affected and, without realizing any of the benefits of having completed the sale, the Company would be subject to a number of risks, including the following:

The Company may experience negative reactions from the financial markets, including negative impacts on the trading price of its common stock, which could affect its ability to secure sufficient financing in the future on attractive terms (or at all);
The Company will be required to pay its transaction-related expenses incurred in connection with the Purchase and Sale Agreement whether or not the sale is completed;
Matters related to the sale of the Property may require substantial commitments of time and resources by the Company’s management, which could otherwise have been devoted to other opportunities that may have been beneficial to the Company.

In addition, the Company could be subject to litigation related to any failure to complete the sale. If the sale of the Property is not completed, the Company cannot assure its stockholders that the risks described above will not materialize and will not materially and adversely affect the Company’s business, financial condition, financial results and common stock prices.

If the sale of the Property is not completed, The Company will have incurred substantial expenses without realizing the expected benefits of the sale.

The Company has incurred substantial expenses in connection with the negotiation and completion of the transactions contemplated by the Purchase and Sale Agreement. If the sale of the Property is not completed, the Company would have to recognize these expenses without realizing the expected benefits of the sale.

The unaudited pro forma financial information included as an exhibit to this Current Report on Form 8-K is for illustrative purposes and the Company’s actual financial position or results of operations after the anticipated sale may differ materially.

The unaudited pro forma financial information included as an exhibit to this Current Report on Form 8-K is presented for illustrative purposes only and is not necessarily indicative of what the Company’s actual financial position or results of operations would have been had the sale been completed on the dates indicated. The unaudited pro forma financial information reflects adjustments, which are based upon estimates. The information upon which these adjustments and assumptions have been made is preliminary, and these kinds of adjustments and assumptions are difficult to make with complete accuracy. Moreover, the pro forma financial information does not reflect all costs that are expected to be incurred by the Company. Accordingly, the final accounting adjustments may differ materially from the pro forma information included as an exhibit to this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

(b) Filed herewith as Exhibit 99.1 are the unaudited Pro Form Condensed Consolidated Balance Sheet as of March 31, 2023. Unaudited Pro Form Condensed Statements of Operations for the Nine Months ended March 31, 2023 and Unaudited Pro Form Condensed Statements of Operations for the Year Ended June 30, 2022.

(d) Exhibits

Exhibit No.

    

Description

10.1†

Purchase and Sale Agreement, dated September 15, 2023, by and between iBio CDMO LLC and Majestic Realty Co.

10.2

Sixth Amendment, dated September 18, 2023, to the Credit Agreement by and between iBio CDMO LLC and Woodforest National Bank

99.1

Unaudited Pro Form Condensed Consolidated Balance Sheet as of March 31, 2023. Unaudited Pro Form Condensed Statements of Operations for the Nine Months ended March 31, 2023 and Unaudited Pro Form Condensed Statements of Operations for the Year Ended June 30, 2022.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

The Company has omitted certain portions of the Purchase and Sale Agreement in accordance with Item 601(b)(10) of Regulation S-K. The Company agrees to furnish unredacted copies of these Exhibits to the SEC upon request.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 21, 2023

IBIO, INC.

By: 

/s/ Marc A. Banjak

Name:

Marc A. Banjak

Title:

General Counsel and Corporate Secretary

Exhibit 10.1

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS EXHIBIT MARKED BY [***] HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL

PURCHASE AND SALE AGREEMENT

THIS PURCHASE AND SALE AGREEMENT (this “Agreement”), dated as of September 15, 2023 (the “Effective Date”), is made by and between MAJESTIC REALTY CO., a California corporation (“Purchaser”) and IBIO CDMO LLC, a Delaware limited liability company (“Seller”).

A G R E E M E N T S:

NOW, THEREFORE, in consideration of the covenants, promises and undertakings set forth herein, and for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Seller and Purchaser agree as follows:

1.THE PROPERTY.

1.1Description. Subject to the terms and conditions of this Agreement, and for the consideration herein set forth, Seller agrees to sell and transfer, respectively, and Purchaser agrees to purchase and acquire, the following (collectively, the “Property”):

1.1.1The ground leasehold estate and interest under that certain (i) Ground Lease Agreement dated March 8, 2010, as amended by an Estoppel Certificate and Amendment to Ground Lease Agreement dated as of December 22, 2015 (the “Ground Lease”) between Seller (as assignee from College Station Investors LLC) and The Board of Regents of the Texas A&M University System (“Ground Lessor”), relating to the land (the “Land”) more specifically described in Exhibit 1.1.1 located in Brazos County, Texas;

1.1.2The buildings, parking areas, improvements, and fixtures now situated on the Land (the “Improvements”);

1.1.3All of Seller’s assignable and transferable right, title, and interest in and to furniture, personal property, machinery, apparatus, and equipment owned by Seller and currently used in the operation, repair and maintenance of the Land and Improvements and situated thereon (collectively, the “Personal Property”);

1.1.4All of Seller’s assignable and transferable right, title, and interest (if any) in and to all easements, hereditaments, and appurtenances belonging to or inuring to the benefit of Seller and pertaining to the Land or Improvements, if any;

1.1.5[reserved];

1.1.6Subject to Section 3.3, all contracts and agreements relating to the operation or maintenance of the Land, Improvements or Personal Property the terms of which extend beyond midnight of the day preceding the Closing Date (as hereinafter defined) as set forth on Exhibit 1.1.6 (the “Contracts”) except for those Contracts which Purchaser elects not to assume pursuant to Section 3.3 of this Agreement; and


1.1.7To the extent not proprietary and without representation as to whether third party consent is required, and at no cost or liability to Seller, all of Seller’s assignable and transferable right, title, and interest (if any) in and to all intangible assets of any nature relating to any or all of the Land, the Improvements and the Personal Property , including, but not limited to, (i) all guaranties and warranties issued with respect to the Personal Property or the Improvements (if any) including equipment and construction warranties and the roof warranty; (ii) all plans and specifications, drawings and prints describing the Improvements; (iii) trademarks or trade names associated with the Improvements; (iv) all development rights; (v) any governmental permits, entitlements, approvals, licenses and certificates (including any pending applications) including without limitation, those pertaining to zoning, use, occupancy, and signage for the Property; and (vi) all rights and claims of Seller against third parties related to the Property (collectively, the “Intangibles”).

1.2“As-Is” Purchase.  The Property is being sold in an “AS IS, WHERE IS” condition and “WITH ALL FAULTS” as of the Effective Date and of Closing, except as expressly set forth in this Agreement including the Exhibits annexed hereto (and incorporated herein by this reference) and/or in the documents to be delivered at Closing (herein collectively referred to as “Seller’s Representations and Warranties”). Except for Seller’s Representations and Warranties, no representations or warranties have been made or are made and no responsibility has been or is assumed by Seller or by any partner, officer, person, firm, agent, attorney or representative acting or purporting to act on behalf of Seller as to (i) the condition or state of repair of the Property; (ii) the compliance or non-compliance of the Property with any applicable laws, regulations or ordinances (including, without limitation, any applicable zoning, building or development codes); (iii) the value, expense of operation, or income potential of the Property; (iv) any other fact or condition which has or might affect the Property or the condition, state of repair, compliance, value, expense of operation or income potential of the Property or any portion thereof; or (v) the environmental condition of the Property, including without limitation whether the Property contains asbestos or harmful or toxic substances or pertaining to the extent, location or nature of same.  The parties agree that all understandings and agreements heretofore made between them or their respective agents or representatives are merged in this Agreement and the Exhibits hereto annexed, which alone fully and completely express their agreement, and that this Agreement has been entered into after full investigation, or with the parties satisfied with the opportunity afforded for full investigation, neither party relying upon any statement or representation by the other except for Seller’s Representations and Warranties.  Purchaser acknowledges and agrees that (a) Purchaser has, or will have prior to the Due Diligence Deadline, independently examined, inspected, and investigated to the full satisfaction of Purchaser, the physical nature and condition of the Property including, without limitation, its environmental condition, and the income, operating expenses and carrying charges affecting the Property, and (b) except for Seller’s Representations and Warranties, Purchaser, in executing, delivering and performing this Agreement, does not rely upon any statement, offering material, operating statement, historical budget, engineering structural report, any environmental reports, information, or representation to whomsoever made or given, whether to Purchaser or others, and whether directly or indirectly, orally or in writing, made by any person, firm or corporation, and Purchaser acknowledges that any such statement, information, offering material, operating statement,

Page 2


historical budget, report or representation, if any, does not represent or guarantee future performance of the Property.

To the extent now or hereafter applicable, each party hereby waives its rights, if any, under the Deceptive Trade Practices – Consumer Protection Act, Section 17.41 et seq., Texas Business & Commerce Code, a law that gives consumers special rights and protections.  After consultation with an attorney of its own selection, each party voluntarily consents to this waiver.

This Section 1.2 shall survive any termination of this Agreement and the Closing.

1.3Agreement to Convey. Subject to the terms and conditions set forth in this Agreement, including but not limited to, Seller’s Representations and Warranties, Seller agrees to convey, and Purchaser agrees to accept, the Property, including Seller’s ground leasehold interest in the Land and Improvements under the Ground Lease pursuant to the Assignment and Assumption of Ground Lease pursuant to Section 9.2.1 below, and title to the Personal Property pursuant to a Bill of Sale and Assignment and Assumption Agreement pursuant to Section 9.2.3 below.

2.PRICE AND PAYMENT.

2.1Purchase Price. Purchaser agrees to pay the sum of Seventeen Million Two Hundred Fifty Thousand Dollars and No cents ($17,250,000.00) (the “Purchase Price”) for the acquisition of the Property, subject to the terms of this Agreement.

2.2Payment. Payment of the Purchase Price is to be made in cash as follows:

2.2.1Within two (2) business days of the execution of this Agreement, Purchaser shall deliver, as an earnest money deposit with Chicago Title Insurance Company, 23929 Valencia Blvd., Suite 304, Valencia, CA 91355, Attn: Maggie G. Watson; Telephone: (661) 753-5701; Email: Maggie.Watson@ctt.com (the “Title Company” or “Escrow Holder, the sum of $200,000.00 (the “Deposit”).

2.2.2The Deposit will be placed with and held in escrow by the Title Company, in immediately available funds in an interest-bearing account at a mutually acceptable banking institution.  Any interest earned by the Deposit shall be considered as part of the Deposit.  Except as otherwise provided in this Agreement, the Deposit will be applied to the Purchase Price at Closing.

2.2.3Notwithstanding anything herein to the contrary, upon any return of the Deposit to Purchaser, there shall first be deducted and delivered to Seller an amount equal to One Hundred Dollars ($100) (the “Independent Consideration”), which amount Purchaser and Seller bargained for and agreed to as consideration for Seller’s execution, delivery and performance of this Agreement and the right of Purchaser to terminate this Agreement as provided herein.  The Independent Consideration is in addition to and independent of any other consideration or payment provided in this Agreement.

Page 3


2.2.4At Closing, Purchaser shall pay the balance of the Purchase Price, subject to adjustment for the prorations as provided herein, to the Title Company for disbursement to Seller via wire transfer in immediately available funds.

2.3Closing.  Payment of the Purchase Price and the closing hereunder (the “Closing”) will take place pursuant to an escrow closing on, time being of the essence, December 1, 2023, or such later date as may be mutually agreed upon in writing by the parties (the “Closing Date”), provided Purchaser does not terminate this Agreement prior to such date in accordance with this Agreement.  The Closing will take place at the offices of the Title Company at 4:00 p.m. local time or at such other time and place as may be agreed upon in writing by Seller and Purchaser.  Closing shall occur through an escrow with the Title Company.  Funds shall be deposited into and held by the Title Company in a closing escrow account with a bank satisfactory to Purchaser and Seller.  Upon satisfaction or completion of all closing conditions and deliveries, the parties shall direct the Title Company to immediately record and deliver the closing documents to the appropriate parties and make disbursements according to the closing statements executed by Seller and Purchaser.

3.INSPECTIONS AND APPROVALS.

3.1Inspections.

3.1.1Commencing on the Effective Date through the Closing Date, so long as this Agreement remains in effect, Seller agrees to allow Purchaser and Purchaser’s engineers, architects, employees, agents and representatives (collectively, “Purchaser’s Agents”) reasonable access, during normal business hours, to the Property and to the records, if any, maintained by Seller or maintained for Seller by the Property Manager.  Such access shall be solely for the purposes of (i) reviewing records relating to construction, repair, maintenance and operating expenses; and (ii) inspecting the physical condition of the Property and conducting non-intrusive physical or environmental inspections of the Property.  Purchaser shall not conduct or allow any testing or air samples at the Property or any physically intrusive testing of, on or under the Property without first obtaining Seller’s written consent as to the timing and scope of work to be performed and entering into an access agreement in form and substance satisfactory to Seller in its sole discretion; provided, however, for the avoidance of doubt, Purchaser shall be entitled to conduct a customary Phase I Environmental Assessment.  Except as expressly set forth in this Agreement, all documents furnished to Purchaser pursuant to this Agreement are provided for information only, and without representation or warranty of any nature, and Purchaser shall be solely responsible for verifying the information contained therein. Purchaser shall not file or cause to be filed any application or make any request (other than inquiries into public records and existing violations) with any governmental or quasi-governmental agency (other than TAMU) which would or could lead to a hearing before any governmental or quasi-governmental agency or which would or could lead to a note, notice or violation of law or municipal ordinance, order or requirement imposed by such an agency, at the Property or any change in zoning, parcelization, licenses, permits or other entitlements or any investigation or restriction on the use of the Property, or any part thereof.

Page 4


3.1.2Purchaser agrees that, in making any physical or environmental inspections of the Property, Purchaser shall carry, or cause Purchaser’s Agents to carry insurance in form and substance consistent with the requirements set forth on Exhibit 3.1.2, naming Seller and, if required under the Ground Lease, Ground Lessor, as additional insureds and Purchaser will provide Seller with written evidence of same prior to entry on the Property.

3.1.3Purchaser agrees that in exercising its right of access hereunder, Purchaser will use and will cause Purchaser’s Agents to use their commercially reasonable efforts not to interfere with the activity of tenants or any persons occupying or providing service at the Property.  Purchaser shall, at least forty-eight (48) hours prior to inspection, give Seller notice, which may be verbal, of its intention to conduct any inspections, so that Seller shall have an opportunity to have a representative present during any such inspection, and Seller expressly reserves the right to have such a representative present.  Seller agrees that [***] will be Seller’s contact person for scheduling such inspections.  Upon request by Seller, Purchaser shall furnish Seller with copies of any final reports relating to the inspections performed by Purchaser or Purchaser’s Agents; provided, however, that such reports will be delivered without representation or warranty of any kind, express or implied, as to the accuracy or completeness thereof. If Purchaser fails to purchase the Property, upon request by Seller, all such final reports shall become the property of Seller. Upon request by Seller, Purchaser agrees to cooperate with Seller (at no additional cost to Purchaser) and the preparer of the reports to have such reports assigned to Seller.

3.1.4Purchaser shall, at its sole cost and expense and in strict accordance with all requirements of applicable law, promptly restore any physical damage or alteration of the physical condition of the Property (reasonable wear and tear excepted) which results from any inspection or activity conducted by Purchaser or any Purchaser’s Agent; provided, however, Purchaser shall have no obligation to restore any pre-existing environmental or other pre-existing conditions in, on or under the Property, except to the extent such conditions are exacerbated by Purchaser or any Purchaser’s Agents. The provisions of this Section 3.1.4 shall survive any termination of this Agreement.

3.1.5Except for Seller’s Representations and Warranties or as otherwise provided for elsewhere in this Agreement or the documents to be delivered at Closing, Seller makes no representations or warranties as to the truth, accuracy, completeness, methodology of preparation or otherwise concerning any engineering or environmental reports or any other materials, data or other information supplied to Purchaser in connection with Purchaser’s inspection of the Property (e.g., that such materials are complete, accurate or the final version thereof, or that such materials are all of such materials as are in Seller’s possession).  In making its own examination and determination prior to the Due Diligence Deadline (defined below) as to whether it wishes to purchase the Property, except for Seller’s Representations and Warranties, Purchaser shall rely exclusively on its own independent investigation and evaluation of every aspect of the Property and not on any materials supplied by Seller.

3.1.6PURCHASER AGREES (WHICH AGREEMENT SHALL SURVIVE CLOSING OR TERMINATION OF THIS AGREEMENT) TO INDEMNIFY, DEFEND, AND HOLD SELLER HARMLESS FROM ANY LIABILITIES, LOSS, INJURY, DAMAGE,

Page 5


CLAIM, LIEN, COST OR EXPENSE, INCLUDING ATTORNEYS’ FEES AND COSTS (COLLECTIVELY, “CLAIMS”), TO THE EXTENT THE SAME HAS RESULTED FROM THE EXERCISE BY PURCHASER OR PURCHASER’S AGENTS OF THE RIGHT OF ACCESS ON THE PROPERTY, INCLUDING WITHOUT LIMITATION ARISING OUT OF INJURY OR DEATH TO PERSONS OR DAMAGE TO PROPERTY (COLLECTIVELY, “PURCHASER’S INDEMNITY OBLIGATIONS”); PROVIDED, HOWEVER, THAT PURCHASER’S INDEMNITY OBLIGATIONS SHALL NOT INCLUDE (i) ANY CLAIMS ARISING OUT OF THE DISCOVERY OF ANY PRE-EXISTING ENVIRONMENTAL OR OTHER CONDITION AT THE PROPERTY, EXCEPT TO THE EXTENT THE SAME HAS BEEN EXACERBATED BY PURCHASER OR PURCHASER’S REPRESENTATIVES; AND (ii) ANY CLAIMS (AS DEFINED ABOVE) TO THE EXTENT OF THE NEGLIGENCE OR WILLFUL MISCONDUCT OF SELLER OR ANY OF THE OTHER SELLER RELEASED PARTIES.  THIS SECTION 3.1.6 SHALL SURVIVE CLOSING OR THE TERMINATION OF THIS AGREEMENT. Purchaser hereby waives, releases and forever discharges Seller, its affiliates, subsidiaries, officers, directors, shareholders, employees, independent contractors, partners, representatives, agents, successors and assigns, and each of them (the “Seller Released Parties”), from any and all causes of action, claims, assessments, losses, damages (compensatory, punitive or other), liabilities, obligations, reimbursements, costs and expenses of any kind or nature, actual, contingent, present, future, known or unknown, suspected or unsuspected, including, without limitation, interest, penalties, fines, and attorneys’ and experts’ fees and expenses, arising out of Purchaser’s access or the inspections under Section 3 of this Agreement, except to the extent of the negligence or willful misconduct of Seller or any of the other Seller Released Parties. This Section 3.1.6 shall survive the termination of this Agreement.

3.1.7Any and all work with respect to Purchaser’s inspections shall be at Purchaser’s sole cost and expense and all activities undertaken by Purchaser in connection therewith shall fully comply with applicable laws and regulations. Purchaser shall keep the Property free from any liens arising out of any work performed, materials furnished, or obligations incurred by or on behalf of Purchaser or Purchaser’s Agents with respect to any inspection or testing of the Property.  If any such lien at any time shall be filed, Purchaser shall cause the same to be discharged of record within ten (10) days following Purchaser’s receipt of written notice of such lien by satisfying the same or, if Purchaser, in its discretion and in good faith determines that such lien should be contested, by recording a bond.  Failure by Purchaser to discharge such lien shall be a material breach of this Agreement. Purchaser agrees to keep confidential and not to disseminate to any third party, except to its Representatives (defined below), and to cause its Representatives to keep confidential and not disseminate to any third party, any information Purchaser (and/or its Representatives) obtains as a result of the Inspections, except (i) to the extent disclosure is required by law or court order (subject to the provisions of Section 11.7 below) or  (ii) with respect to information that (a) is already in the receiving party’s possession prior to receipt from the disclosing party, (b) becomes generally available to the public other than as a result of a disclosure by the receiving party, or (c) becomes available to the receiving party on a non-confidential basis from a source not known by the receiving party to be bound by a confidentiality agreement with or other obligation of secrecy to the disclosing party.

Page 6


3.1.8Purchaser understands that any financial statements and data, including, without limitation, gross rental income, operating expenses and cash flow statements, which may be made available by Seller to Purchaser, will be unaudited financial statements and data not prepared or reviewed by independent public accountants, and that Seller makes no representation as to the accuracy or completeness thereof, except for Seller’s Representations and Warranties.

3.2Title and Survey.

3.2.1Within 3 days following the Effective Date, Seller shall order for Purchaser a commitment for title insurance on the Land, together with copies of all items shown as exceptions to title therein, issued by the Title Company on behalf of Chicago Title Insurance Company (the “Title Commitment”), and a copy of Seller’s existing survey of the Land (the “Survey”).  Purchaser shall have until October 12, 2023 (the “Title Approval Date”) to provide written notice to Seller of any matters shown by the Title Commitment or Survey which are not satisfactory to Purchaser, which notice (the “Title Notice”) must specify the reason such matter(s) are not satisfactory and the curative steps necessary to remove the objections stated in the Title Notice (collectively, the “Title Objections”).

3.2.2In the event Seller is unable or unwilling to eliminate or modify all of the Title Objections, Seller shall so notify Purchaser in writing on or before such date that is two (2) business days following receipt of the Title Notice, and Purchaser may (as its sole and exclusive remedy) terminate this Agreement by delivering written notice thereof to Seller not later than the Due Diligence Deadline (defined below).  Except for Seller Cure Matters (as defined below), which Seller shall be obligated to remove or cure at or prior to Closing, Seller shall have no obligation whatsoever to expend or agree to expend any funds, to undertake or agree to undertake any obligations or otherwise to cure or agree to cure any Title Objections.

3.2.3Except as provided herein, Purchaser’s sole right with respect to any Title Objection (other than Seller Cure Matters) shall be to elect on or before the Due Diligence Deadline (defined below) to terminate this Agreement, other than continuing obligations under Sections 3.1.4 and 3.1.6 that survive the Closing or termination of this Agreement) (herein called the “Surviving Obligations”) and to receive a refund of the Deposit.

3.2.4Except for Seller Cure Matters, all matters shown on the Title Commitment and/or Survey and any update of such Survey (an “Updated Survey”) with respect to which Purchaser fails to give a Title Notice on or before the last date for so doing, or with respect to which a timely Title Notice is given but Seller fails to respond or declines to cure shall be deemed to be approved by Purchaser and a “Permitted Encumbrance” as provided in Section 3.4 hereof, subject, however, to Purchaser’s termination right provided in Section 3.5 hereof.  In no event shall any Seller Cure Matters constitute a Permitted Encumbrance and Purchaser shall have no obligation to raise any such Seller Cure Matters in any Title Notice.

3.2.5Seller shall be obligated to cure and remove (or procure title insurance over to the reasonable satisfaction of Purchaser) all of the following (“Seller Cure Matters”), if any:  (a) the liens of any mortgage, trust deed, deed of trust and financing statements evidencing or

Page 7


securing an indebtedness owed by Seller or other lien securing the payment of monetary obligation voluntarily created by Seller or consented to in writing by Seller after the date hereof; (b) tax liens for delinquent ad valorem real estate taxes or other assessments or governmental charges due from Seller affecting all or any portion of the Property that are delinquent or that will be delinquent as of  the Closing Date; and (c) any recorded encumbrances or restrictions against the Property caused by Seller after the Effective Date without Purchaser’s prior written consent.

3.2.6If any update to the Title Commitment after the effective date of the Title Commitment or to the Survey after the date of the Survey set forth in the Title Notice discloses any new title exception or matter not disclosed in the Title Commitment, the Survey and/or in the Title Notice which, in each case (other than with respect to Required Cure Matters, which Seller shall be obligated to cure), has a material and adverse effect on the Property (a “New Exception”), then provided that any such New Exception was not created by or through Purchaser, Purchaser shall have a period of three (3) Business Days after delivery of such update to review and notify Seller in writing of Purchaser’s disapproval of such New Exception, if any.  Upon the expiration of said three (3) Business Day period, except for Purchaser’s timely submitted objection to any such New Exception, Purchaser shall be deemed to have accepted each such New Exception, if any. Seller may respond to Purchaser’s timely submitted objection to any New Exception within three (3) Business Days after receipt thereof.  If Seller fails to respond within such three (3) Business Day period, Seller shall be deemed to have delivered Seller’s election to not cure or remove any of Purchaser’s objections to any New Exception.  If Seller elects (or is deemed to have elected) to not cure or remove to the reasonable satisfaction of Purchaser any New Exception (other than with respect to Seller Cure Matters) prior to Closing (as may be extended), Purchaser may, in its sole and absolute discretion, within three (3) Business Days after notice (or deemed notice) of Seller’s intent to not cure or remove any New Exception, deliver written notice to Seller of Purchaser’s decision to (i) terminate this Agreement, whereupon the entire Deposit (less the independent consideration) shall be returned to Purchaser and this Agreement shall terminate without any further liability on the part of either party, except for the Surviving Obligations, or (ii) waive its objections in which event Closing will take place the later of the Closing Date and three (3) business days after notice (or deemed notice) per this Section 3.2.6.

3.2.7Seller shall be entitled to one or more adjournments of the Closing for a period not to exceed twenty (20) days beyond the scheduled date for Closing in order to remove or satisfy any lien, encumbrance, defect, encroachment or objection which is not a Permitted Encumbrance and that Seller is required (in the case of Required Cure Matters) or has agreed to remove or satisfy.

3.3Contracts.  On or before the Fee Purchase Agreement Deadline (defined below), Purchaser shall notify Seller in writing if Purchaser elects not to assume at Closing any of the service, maintenance, supply or other contracts relating to the operation of the Property which are identified on Exhibit 1.1.6 attached hereto. If Purchaser does not exercise its right to terminate this Agreement on or before the Fee Purchase Agreement Deadline, Seller shall give notice of termination of such disapproved contract(s) provided the same are terminable, except Seller shall have no obligation to terminate, and Purchaser hereby agrees to accept and assume all Contracts

Page 8


(including those specified in Purchaser’s notice) which cannot be terminated by Seller (i) without cause, (ii) upon thirty (30) days’ notice or less, or (iii) without payment of a premium or penalty. Purchaser’s failure to timely deliver notice pursuant to the preceding sentence shall be deemed Purchaser’s election to accept and assume all of the Contracts. Notwithstanding the foregoing, Seller shall terminate any existing property management agreement and any leasing agreements at or prior to the Closing Date and shall terminate any other Contracts that are terminable, and that Purchaser elects not to assume as of the Closing Date, in each case at no cost to Purchaser.

3.4Permitted Encumbrances. In addition, Purchaser shall be deemed to have approved and to have agreed to purchase the Property subject to the following:

3.4.1All exceptions to title shown in the Title Commitment or matters shown on the Survey which Purchaser has approved or is deemed to have approved pursuant to Section 3.2 hereof, except for Seller Cure Matters;

3.4.2The lien of non-delinquent real and personal property taxes and assessments for the year in which the Closing occurs and subsequent years; however, Seller will be responsible for the payment of any so-called “rollback taxes” due and payable prior to the Closing Date for all or any portion of the Property and as a result of a change of use of the Property.

3.4.3Terms and conditions of the Ground Lease.

3.4.4Shortages in area.

3.4.5Any laws, regulations or ordinances presently in effect or which will be in effect on the Closing (including, but not limited to, zoning, building and environmental protection) as to the use, occupancy, subdivision or improvement of the Property adopted or imposed by any governmental body or the effect of any noncompliance with or any violation thereof.

3.4.6Right of any utility company to maintain and operate lines, wires, poles, cables and distribution boxes, in, over and upon the Property.

3.4.7Unpatented mining claims; reservations or exceptions in patents or in acts authorizing the issuance thereof, water rights, claims or title to water, whether or not shown by the public records.

All of the foregoing in Sections 3.4.1 through 3.4.5 are referred to herein collectively as “Permitted Encumbrances.”  Notwithstanding the foregoing, the Permitted Encumbrances shall not include the Seller Cure Matters.

3.5Purchaser’s Rights to Terminate.

3.5.1Property Due Diligence Deadline. If, following Purchaser’s due diligence investigations as contemplated in this Section 3.1, Purchaser approves of the condition of the Property in its sole and absolute discretion, then Purchaser shall notify Seller of Purchaser’s

Page 9


election to continue this Agreement in effect by causing a written notice of such election (a “Purchaser’s Property Approval Notice”) to be given to Seller and to Escrow Holder at any time on or before 5:00 p.m. Central time on October 16, 2023 (the “Due Diligence Deadline”). If Purchaser fails to deliver said Purchaser’s Property Approval Notice to Seller and Escrow Holder by the expiration of the Due Diligence Deadline, Purchaser shall be deemed to have elected to terminate this Agreement, in which event the Title Company shall promptly return the Deposit to Purchaser (less the Independent Consideration) and neither party shall have any further liability hereunder except for the Surviving Obligations.  If Purchaser’s Property Approval Notice is given prior to the Due Diligence Deadline, Purchaser shall have no further right to terminate this Agreement pursuant to this Section 3.5.1 and the one-half of the Deposit (equal to $100,000.00) (the “Non-Refundable Portion”) shall be non-refundable except as expressly provided in this Agreement. For the avoidance of doubt, the other one-half of the Deposit (equal to $100,000.00) shall be refundable to Purchaser in accordance with the terms of Section 3.5.2.

3.5.2TAMU Approval Deadline. Purchaser shall have until 5:00 p.m. Central time on November 13, 2023 (the “TAMU Approval Deadline”) in order to obtain the approval of the Board of Regents of Ground Lessor (the “TAMU Approval”) to the purchase by Purchaser of the fee interest in that certain approximately 21.401 acres of land and improvements thereon (the “TAMU Purchase Tract,” and described on Exhibit 3.5.2(i) and depicted on Exhibit 3.5.2(ii) attached hereto. If Purchaser obtains the TAMU Approval by the TAMU Approval Deadline, then Purchaser shall notify Seller of Purchaser’s election to continue this Agreement in effect by causing written notice of such election (a “Purchaser’s TAMU Approval Notice”) to be given to Seller and to Escrow Holder prior to the TAMU Approval Deadline. If Purchaser fails to timely deliver Purchaser’s TAMU Approval Notice to Seller and Escrow Holder, Purchaser shall be deemed to have elected to terminate this Agreement, in which event the Title Company shall promptly return one-half of the Deposit to Purchaser (less the Independent Consideration) and deliver the Non-Refundable Portion of the Deposit to Seller and neither party shall have any further liability hereunder except for the Surviving Obligations. If Purchaser’s TAMU Approval Notice is given prior to the TAMU Approval Deadline, Purchaser shall have no further right to terminate this Agreement pursuant to this Section 3.5.2 and the entire the Deposit (equal to $200,000.00) shall be non-refundable except as expressly provided in this Agreement.

3.6Delivery of Title Policy at Closing.  As a condition to Purchaser’s obligation to close, the Title Company shall deliver to Purchaser at Closing, a Texas standard form Leasehold Policy of Title Insurance (the “Title Policy”) issued by the Title Company as of the date and time of the recording of the Assignment and Assumption of Ground Lease, in the amount of the Purchase Price, insuring Purchaser as owner of the indefeasible leasehold interest to the Property under the Ground Lease and the Improvements, subject only to the Permitted Encumbrances.  Seller shall execute at Closing the form of title affidavit attached hereto as Exhibit 3.6 or otherwise acceptable to Title Company to facilitate the issuance of the Title Policy. The Title Policy may be delivered after the Closing if at the Closing the Title Company issues a currently effective pro forma policy and irrevocably commits in writing to issue the Title Policy in the form of the pro forma policy approved by Purchaser within 10 days after the Closing Date.  Purchaser may elect to obtain additional coverage or endorsements to the Title Policy at Purchaser’s sole cost and

Page 10


expense but obtaining such additional coverage or endorsements shall not be a condition precedent to Purchaser’s Closing obligations under this Agreement. Seller shall be responsible for the basic premium payable for Purchaser’s Title Policy (excluding the cost of any extended coverage thereto and the cost of any lender’s policy of title insurance)

4.SELLER’S COVENANTS FOR PERIOD PRIOR TO CLOSING.  Until closing, Seller shall:

4.1Insurance.  Keep the Property insured under its current or comparable policies against fire and other hazards covered by extended coverage endorsement and commercial general liability insurance against claims for bodily injury, death and property damage occurring in, on or about the Property.

4.2Operation. Operate and maintain the Property substantially in accordance with Seller’s past practices with respect to the Property, normal wear and tear excepted, except that Seller shall have no obligation whatsoever to make any capital expenditures that do not arise out of the acts of Seller. At all times from the Effective Date to the Closing, Seller shall keep and perform all of the obligations to be performed by the tenant under the Ground Lease. Seller may not remove any Personal Property from the Improvements without replacing them with items of like kind (or utility) and quality prior to Closing. Seller shall maintain all insurance policies in effect as required under the Ground Lease. Seller shall give to Purchaser prompt written notice of any casualty or the institution by Seller or receipt of written notice or other knowledge by Seller of any litigation pertaining to the Property and/or any threatened condemnation, or material litigation, arbitration, or administrative hearing affecting the Seller or the Property which could in any way constitute, or have the effect of presently or in the future creating, a lien, encumbrance or claims or obligations in any material respect against the Property or the leasehold estate under the Ground Lease. Seller shall not further encumber any portion of the Property or its leasehold estate under the Ground Lease in any manner without the consent of Purchaser.

4.3New Contracts. Following the Effective Date, Seller shall not enter into any new contract or agreement with respect to the ownership and operation of the Property that would be binding on Purchaser or the Property after the Closing Date, without Purchaser’s prior written approval, not to be unreasonably withheld.  Seller shall keep all Warranties in effect in accordance with their terms to the Closing Date.

4.4New Leases.  From the Effective Date through the Closing or earlier termination of this Agreement, Seller will not enter into any sublease of any space in the Improvements or terminate or amend any existing sublease without in each case the consent of Purchaser in its sole and absolute discretion.

5.REPRESENTATIONS AND WARRANTIES.

5.1By Seller.  Seller represents and warrants to Purchaser as follows:

Page 11


5.1.1Seller is duly organized and validly existing under the laws of the State in which it was organized, is authorized to do business in the State in which the Land is located, has duly authorized the execution and performance of this Agreement, and such execution and performance will not violate any material term of its articles of incorporation or bylaws.

5.1.2Performance of this Agreement will not result in any breach of, or constitute any default under, or result in the imposition of any lien or encumbrance upon the Property under, any agreement to which Seller is a party, including under the Ground Lease.

5.1.3There is no pending litigation with respect to the Property nor, to the best of Seller’s knowledge, have any such actions, suits, proceedings or claims been threatened or asserted in writing, which could have an adverse effect on the Property or Seller’s ability to consummate the transactions contemplated hereby.

5.1.4Seller has not received any written notice from any Governmental Authority (as hereinafter defined) of a violation of any governmental requirements (including environmental laws) on the Property, which has not been remedied.

5.1.5Seller has not received, with respect to the Property, written notice from any Governmental Authority regarding any change to the zoning classification, any condemnation proceedings or proceedings to widen or realign any street or highway adjacent to the Property.

5.1.6Except for Seller, there are no other parties in possession of, or claiming any possession to, any portion of the Improvements. There are no subleases in place with respect to the Property.

5.1.7As of the Effective Date, neither Seller, nor any affiliate or agent on Seller’s behalf, has entered into an agreement for construction or repair work at the Property that could give rise to any claim for mechanic’s or materialman’s liens.

5.1.8The list of Contracts attached as Exhibit 1.1.6 is true, correct and complete in all material respects as of the date of delivery. Except as shown on Exhibit 1.1.6, there are no Contracts in place with respect to the Property. Seller has provided to Purchaser true, correct and complete copies of each of such Contracts. Seller has not delivered or received any notice of default under any Contract.

5.1.9Seller is not a “foreign person” within the meaning of Sections 1445 and 7701 the Internal Revenue Code of 1986, as amended (hereinafter, the “Code”).

5.1.10Seller represents that neither Seller nor any of its affiliates, nor any of their respective partners, members, shareholders or other equity owners, and none of their respective employees, officers, directors, representatives or agents is, nor will they become, a person or entity with whom United States persons or entities are restricted from doing business under regulations of the Office of Foreign Asset Control (“OFAC”) of the Department of the Treasury (including those named on OFAC’s Specially Designated Nationals and Blocked Persons List) or under any

Page 12


statute, executive order (including the September 24, 2001, Executive Order Blocking Property and Prohibiting Transactions with Persons Who Commit, Threaten to Commit, or Support Terrorism), or other governmental action and is not and will not engage in any dealings or transactions or be otherwise associated with such persons or entities.

5.1.11No petition in bankruptcy (voluntary or otherwise), assignment for the benefit of creditors, or petition seeking reorganization or arrangement or other action under federal or state bankruptcy laws is pending against or contemplated by Seller.

5.1.12There are no special or other assessments for public improvements or otherwise currently affecting the Property, and Seller has not received notice of (a) any threatened special assessments affecting the Property or (b) any contemplated improvements affecting the Property which may result in special assessments affecting the Property. There are no past due taxes or assessments with respect to the Property.

5.1.13There are no pending real estate tax protests or proceedings affecting the Property.  Seller has not retained any person or firm to file any notice of protest against, or to commence any action to review, any real property tax assessment against the Property.

5.1.14There are no agreements in effect with any broker or other agent obligating Seller to pay a commission or other compensation with respect to the leasing or sale of the Property that will survive Closing.

5.1.15The Ground Lease is the only agreement in effect between Seller and the Ground Lessor or its affiliates. The copy of the Ground Lease made available by Seller for review by Purchaser is a true and correct copy of the Ground Lease. The Ground Lease has not been modified or amended and remains in full force and effect. Seller is the sole owner of the lessee’s interest under the Ground Lease and Seller has not been assigned, pledged or otherwise encumbered such interests in the Ground Lease except for matters that will be released at or prior to Closing. Seller has received no written notice nor delivered any written notice that: (i) Seller is in default under the Ground Lease; and (ii) Ground Lessor is alleging that Seller has not complied with any of its obligations under the Ground Lease. Other than the approval of the Ground Lessor in accordance with the Ground Lease, Seller does not need to obtain the consent of any third party to the assignment of the Ground Lease or the consummation of the transaction contemplated hereby.

5.1.16Seller has not granted any option to purchase or right of first refusal or other preferential right with respect to the Property.

5.1.17Seller has made available to Purchaser copies of all environmental assessments, reports or other studies in Seller’s possession or control related to Hazardous Materials in, on, under, or that may be released from the Property and such copies are true, correct and complete. As of the date of this Contract, Seller has not received any written warning, notice, notice of violation, administrative complaint, judicial complaint, or other form or informal notice or request for information alleging that Hazardous Materials have been stored or released at the

Page 13


Property, that conditions at the Property are in violation of any Law, or requesting information regarding the use, storage, release, or potential release of Hazardous Materials at the Property.  “Hazardous Materials” shall mean materials, wastes or substances that are (A) included within the definition of any one or more of the terms “hazardous substances”, “hazardous materials”, “toxic substances”, “toxic pollutants” and “hazardous waste” in the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended (42 U.S.C. Sections 9601, et seq.), the Resource Conservation and Recovery Act of 1976 (42 U.S.C. Section 6901, et seq.), the Clean Water Act (33 U.S.C. Section 1251, et seq.), the Safe Drinking Water Act (14 U.S.C. Section 1401, et seq.), the Hazardous Materials Transportation Act (49 U.S.C. Section 1801, et seq.), and the Toxic Substance Control Act (15 U.S.C. Section 2601, et seq.) and the regulations promulgated pursuant to such Laws, (B) regulated, or classified as hazardous or toxic, under federal, state or local environmental Laws or regulations, (C) petroleum, (D) asbestos or asbestos-containing materials, (E) polychlorinated biphenyls, (F) flammable explosives or (G) radioactive materials.

The representations and warranties of Seller set forth in this Section 5.1 are made as of the Effective Date and are remade as of the Closing Date. All of the representations and warranties contained in Section 5.1 shall survive the Closing for nine (9) months following the Closing Date (the “Survival Period”).  Each such representation and/or warranty shall automatically be null and void and of no further force and effect after the Survival Period unless, prior to the expiration of the Survival Period, Purchaser shall have commenced a legal proceeding against Seller alleging that Seller was in breach of such representation or warranty when made, and that Purchaser has suffered actual damages as a result thereof (a “Proceeding”). If Purchaser shall have timely commenced a Proceeding, and a court of competent jurisdiction shall, pursuant to a final, non-appealable order in connection with such Proceeding, determine that (1) Seller was in breach of a representation or warranty as of the date made (but accounting for all updates permitted hereunder), (2) Purchaser suffered actual damages (as distinguished from consequential damages) (the “Damages”) by reason of such breach, and (3) that Purchaser did not have actual knowledge of such breach on or prior to Closing, then Purchaser shall be entitled to receive an amount equal to its Damages; provided, however that, notwithstanding the foregoing, in no event shall Purchaser be entitled to sue, seek, obtain or be awarded Damages from Seller, unless and until the aggregate amount of Damages for which Seller is obligated to indemnify Purchaser exceeds the sum of Fifty Thousand and 00/100 Dollars ($50,000.00) (the “Base Amount”), whereupon Seller shall be liable to Purchaser for all Damages related to such Proceeding (i.e., liability shall commence at $0.01 if the Base Amount is surpassed), but in no event will Seller be liable to Purchaser to the extent that the aggregate Damages to Purchaser exceed $2,000,000.00. For the avoidance of doubt, Purchaser shall not have an obligation to prove that it had no knowledge of such breach prior to Closing, but Seller may present evidence of Purchaser’s knowledge as a defense to any Proceeding.

For the purposes of this Agreement the term “to Seller’s knowledge”, and similar terms, shall be limited to the actual knowledge of [***] (the “Seller Knowledge Party”).  The knowledge of others shall not be imputed to the Seller Knowledge Party.   The parties hereby agree that recourse under this Agreement is limited to Seller and no claim will be made against [***] individually or in his capacity as the Seller Knowledge Party.

Page 14


Notwithstanding the foregoing, to the extent that Purchaser, or Purchaser’s Agents obtains actual knowledge prior to Closing that any of Seller’s representations or warranties were untrue in any material respect when made, or if Seller has delivered to Purchaser information with respect to the Property at any time prior to the Closing Date, and such information is inconsistent in any material respect with any of the representations and warranties herein and/or indicate that any such representations or warranties were not true in any material respect when made, Purchaser shall be deemed to have knowledge of such misrepresentation, and Purchaser’s sole remedy as a result thereof shall be to terminate this Agreement and receive a refund of the Deposit, and thereafter, Purchaser and Seller shall have no further rights or obligations under this Agreement except for those which are expressly provided for in this Agreement to survive the termination hereof; and if, notwithstanding such actual knowledge of such breach of a representation, Purchaser elects to close the transactions contemplated by this Agreement, Purchaser shall be deemed to have waived its rights to recover Damages from Seller following the Closing.

5.2By Purchaser.  Purchaser represents and warrants to Seller as follows:

5.2.1Purchaser is duly organized, validly existing and in good standing under the laws of the State in which it was organized, is authorized to do business in the State in which the Land is located, has duly authorized the execution and performance of this Agreement, and such execution and performance will not violate any material term of its organizational documents.

5.2.2Purchaser is acting as principal in this transaction with authority to close the transaction.

5.2.3No petition in bankruptcy (voluntary or otherwise), assignment for the benefit of creditors, or petition seeking reorganization or arrangement or other action under federal or state bankruptcy laws is pending against or contemplated by Purchaser.

5.2.4Purchaser represents that neither Purchaser nor any of its affiliates, nor any of their respective partners, members, shareholders or other equity owners, and none of their respective employees, officers, directors, representatives or agents is, nor will they become, a person or entity with whom United States persons or entities are restricted from doing business under regulations of the Office of Foreign Asset Control (“OFAC”) of the Department of the Treasury (including those named on OFAC’s Specially Designated Nationals and Blocked Persons List) or under any statute, executive order (including the September 24, 2001, Executive Order Blocking Property and Prohibiting Transactions with Persons Who Commit, Threaten to Commit, or Support Terrorism), or other governmental action and is not and will not engage in any dealings or transactions or be otherwise associated with such persons or entities.

The representations and warranties of Purchaser set forth in this Section 5.2 are made as of the Effective Date and are remade as of the Closing Date and Section 5.2 shall survive the Closing.

5.3Broker Representation.  Each of Seller and Purchaser represents to the other that it has had no dealings, negotiations, or consultations with any broker, representative, employee, agent or other intermediary in connection with the Agreement or the sale of the Property, except

Page 15


for CBRE, Inc., a Delaware corporation, who represents Seller (“Seller’s Broker”) and Jones Lang LaSalle Americas, Inc., a Maryland corporation, who represents Purchaser (“Purchaser’s Broker” and collectively with Seller’s Broker, the “Brokers”). Upon the Closing of the transaction contemplated hereby and not otherwise, Seller shall pay a commission to Seller’s Broker pursuant to a separate written agreement between Seller and Seller’s Broker (and Seller’s Broker shall be responsible to pay Purchaser’s Broker pursuant to a separate written agreement(s) between them). For convenience, the parties agree that at Closing, the Title Company shall cause (a) the portion of the commission payable by Seller’s Broker to be paid directly to Purchaser’s Broker in satisfaction of Seller’s Broker’s obligation to Purchaser’s Broker and (b) the remainder to be paid to Seller’s Broker.  Except for the Brokers, Seller and Purchaser agree that each will indemnify, defend and hold the other free and harmless from the claims of any other broker(s), representative(s), employee(s), agent(s) or other intermediary(ies) claiming to have represented Seller or Purchaser, respectively, or otherwise to be entitled to compensation in connection with this Agreement or in connection with the sale of the Property as a result of actions of Seller or Purchaser, respectively.  The terms and provisions of this paragraph shall survive Closing hereunder.

6.COSTS AND PRORATIONS.

6.1Purchaser’s Costs. Purchaser shall pay the following costs of closing this transaction:

6.1.1The fees and disbursements of its counsel, inspecting architect and engineer and any other consultants engaged by Purchaser, if any;

6.1.2The Personal Property, if any, is included in this sale without charge and no value is allocated thereto;

6.1.3The cost of any endorsements or extended coverage to the Title Policy required by Purchaser unless related to a Seller Cure Matter or Title Objections;

6.1.4Any and all recording fees to record Purchaser’s mortgage secured by the Property (if applicable);

6.1.5One-half (1/2) of any and all escrow fees or similar charges of Escrow Holder;

6.1.6All costs relating to updating the Survey; and

6.1.7Any other expense(s) incurred by Purchaser or its representative(s) in inspecting or evaluating the Property or closing this transaction.

6.2Seller’s Costs. Seller shall pay the following costs of closing this transaction:

6.2.1The fees and disbursements of Seller’s counsel.

Page 16


6.2.2Any costs to cure the Seller Cure Matters or other Title Objections that Seller expressly agreed to cure in writing;

6.2.3Reserved;

6.2.4The base premium for the Title Policy in the amount of the Purchase Price;

6.2.5One-half (1/2) of any and all escrow fees or similar charges of Escrow Holder;

6.2.6The cost of recording the Deed;

6.2.7The broker commission payable by Seller to Seller’s Broker and Purchaser’s Broker as provided in Section 5.3.

6.3Prorations.  The following shall be prorated as of the Closing Date and be adjusted against the Purchase Price due at Closing: (a) Rents and other amounts payable to Ground Lessor under the Ground Lease with any obligations due and payable to Ground Lessor which are due and payable prior to the Closing Date to be paid by Seller and any amounts due and payable after the Closing Date to be paid by Purchaser, including, but not limited to, with respect to reconciliations; and (b) personal property taxes, installment payments of special assessment liens, sewer charges, utility charges (utility charges shall be prorated based on the last reading of meters prior to Closing performed at Seller’s request, which meter reading shall be done the day prior to the Closing Date) and normally prorated operating expenses actually billed or paid as of the Closing Date. Within one hundred eighty (180) days after the Closing, Purchaser and Seller will make a further adjustment for such rents, taxes or charges which may have accrued or been incurred prior to the Closing Date, but not billed or paid at that date; such obligations shall survive the Closing.

6.4Taxes.  General real estate and possessory interest taxes and special assessments relating to the Property and/or Seller’s possessory interest under the Ground Lease (collectively, the “Taxes”), if any, payable during the year in which Closing occurs shall be prorated as of the Closing Date.  If Closing shall occur before the actual taxes and special assessments payable during such year are known, the apportionment of Taxes shall be upon the basis of Taxes payable during the immediately preceding year, provided that, if the Taxes payable during the year in which Closing occurs are thereafter determined to be more or less than the Taxes payable during the preceding year (after any appeal of the assessed valuation thereof is concluded), Seller and Purchaser shall promptly within thirty (30) days of receipt of the final tax bill for year of Closing (except in the case of an ongoing tax protest) shall adjust the proration of such Taxes, and Seller or Purchaser, as the case may be, shall pay to the other any amount required as a result of such adjustment and this covenant shall not merge with the instruments executed at Closing and delivered hereunder but shall survive the Closing.  The provisions of this Section 6.4 shall survive Closing or the termination of this Agreement.

Page 17


6.5In General.  Any other costs or charges of closing this transaction not specifically mentioned in this Agreement shall be paid and adjusted in accordance with local custom in the County in which the Land is located.  All prorations shall be made on a 365-day calendar year basis, based on the actual number of days in the applicable month. The provisions of this Section 6.5 shall survive Closing or the termination of this Agreement.

6.6Purpose and Intent.  Except as expressly provided herein, the purpose and intent as to the provisions of prorations and apportionments set forth in this Section 6 and elsewhere in this Agreement is that Seller shall bear all expenses of ownership and operation of the Property and shall receive all income therefrom accruing through midnight at the end of the day preceding the Closing Date and Purchaser shall bear all such expenses and receive all such income accruing thereafter. The provisions of this Section 6.6 shall survive Closing or the termination of this Agreement.

7.DAMAGE, DESTRUCTION OR CONDEMNATION.

7.1Material Event.  If, prior to Closing, the Property is subject to a casualty or a condemnation event which results in (i) [reserved]; (ii) the Improvements being damaged, destroyed or taken under power of eminent domain and the cost of repair exceeds twenty percent (20%) of the Purchase Price (as reasonably determined by Seller and its contractors in consultation with Purchaser), (iii) [reserved]; (iv) any access point used for ingress and egress to the Land rendered permanently or temporarily blocked, (v) the right of Ground Lessor to terminate the Ground Lease, or (vi) damage or destruction which is not insured fully insured (as reasonably determined by Purchaser) and for which Purchaser will not receive a credit in the amount of the uninsured portion of such damage at Closing (collectively, a “Material Event”), then Seller shall promptly notify Purchaser and Purchaser may elect to terminate this Agreement by giving written notice of its election to Seller within seven (7) days after receiving notice of such destruction or taking and the expense to repair, if applicable.  If Purchaser does not give such written notice within such seven (7) day period, this transaction shall be consummated on the Closing Date and at the Purchase Price provided for in Section 2, and Seller will assign to Purchaser the casualty insurance proceeds (including any rent loss proceeds relating to the period from and after Closing) payable to Seller, or Seller’s portion of any condemnation award, in both cases, up to the amount of the Purchase Price, and, if an insured casualty, pay to Purchaser the amount of any deductible but not to exceed the amount of the loss. If requested by Purchaser, Seller hereby agrees to bring and use reasonable efforts to prosecute a claim for recovery under Seller’s insurance policies.

7.2Immaterial Event.  If, prior to Closing, the Property is subject to a casualty or a condemnation event that is not a Material Event, Purchaser shall close this transaction on the date and at the Purchase Price agreed upon in Section 2, and Seller will assign to Purchaser the physical damage proceeds of any insurance policies payable to Seller, or Seller’s rights to any portion of any condemnation award, in both cases, up to the amount of the Purchase Price and, if an insured casualty, pay to Purchaser the amount of any deductible but not to exceed the amount of the loss. If requested by Purchaser, Seller hereby agrees to bring and use reasonable efforts to prosecute a claim for recovery under Seller’s insurance policies.

Page 18


7.3Termination and Return of Deposit.  If Purchaser elects to terminate this Agreement pursuant to this Section 7, Seller shall promptly direct the Title Company to return the Deposit to Purchaser, and neither party shall have any further liability hereunder except for the Surviving Obligations.

8.NOTICES.  Any notice required or permitted to be given hereunder shall be given by (i) hand delivery, (ii) overnight express service, or (iii) email provided notice is also sent by (i) or (ii) above, and in any such case addressed to the parties at their respective addresses referenced below. Notices shall be deemed received upon delivery or refusal of same; any notice received on a non-business day or after 5:00 p.m. Central time on a business day shall be deemed received on the next business day.

Page 19


IF TO SELLER:

iBio, Inc.

11750 Sorrento Valley Road, Suite 200

San Diego, CA 92121

Attn: Felipe Duran, CFO

Email: felipe.duran@ibioinc.com

With Copy to: legal@ibioinc.com

WITH A COPY TO:

Blank Rome LLP

1271 Avenue of the Americas

New York, NY 10020

Attention: Corey Tarzik, Esq.

Email: corey.tarzik@blankrome.com

IF TO PURCHASER:

Majestic Realty Co.

13191 Crossroads Parkway North, 6th Floor

City of Industry, California  91746

Attn: John Semcken

Email: JSemcken@majesticrealty.com

WITH A COPY TO:

Seyfarth Shaw LLP

601 South Figueroa Street, Suite 3300

Los Angeles, California  90017

Attention: Dana S. Treister

Email: Dtreister@seyfarth.com

IF TO TITLE COMPANY:

Chicago Title Insurance Company

23929 Valencia Blvd., Suite 304

Valencia, CA 91355

Attn: Maggie G. Watson

Email: Maggie.Watson@ctt.com

or in each case to such other address as either Purchaser or Seller may from time to time designate by giving notice in writing to the other party.  Effective notice will be deemed given only as provided above. Notices on behalf of the respective parties may be given by their attorneys and such notices shall have the same effect as if in fact given by the party on whose behalf it is given.

9.CLOSING AND ESCROW.

9.1Escrow Instructions.

9.1.1Instructions. Purchaser and Seller each shall promptly deposit a copy of this Agreement executed by such party (or either of them shall deposit a copy executed by both Purchaser and Seller) with Escrow Holder, and, upon receipt of the Deposit from Purchaser, Escrow Holder shall immediately execute this Agreement where provided below. This

Page 20


Agreement, together with such further instructions, if any, as the parties shall provide to Escrow Holder by written agreement, shall constitute the escrow instructions.  If any requirements relating to the duties or obligations of Escrow Holder hereunder are not acceptable to Escrow Holder, or if Escrow Holder requires additional instructions, the parties hereto agree to make such deletions, substitutions and additions hereto as counsel for Purchaser and Seller shall mutually approve, which additional instructions shall not substantially alter the terms of this Agreement unless otherwise expressly agreed to by Seller and Purchaser.

9.1.2Real Estate Reporting Person. Escrow Holder is hereby designated the “real estate reporting person” for purposes of Section 6045 of Title 26 of the United States Code and Treasury Regulation 1.6045-4 and any instructions or settlement statement prepared by Escrow Holder shall so provide. Upon the consummation of the transaction contemplated by this Contract, Escrow Holder shall file Form 1099 information return and send the statement to Seller as required under the aforementioned statute and regulation.  Seller and Purchaser shall promptly furnish their federal tax identification numbers to Escrow Holder and shall otherwise reasonably cooperate with Escrow Holder in connection with Escrow Holder’s duties as real estate reporting person.

9.1.3Liability of Escrow Holder. The parties acknowledge that the Escrow Holder shall be conclusively entitled to rely, except as hereinafter set forth, upon a certificate from Purchaser or Seller as to how the Deposit (which, for purposes of this Section 9.1.3 shall be deemed to also include any other escrowed funds held by the Escrow Holder pursuant to this Agreement) should be disbursed.  Any notice sent by Seller or Purchaser (the “Notifying Party”) to the Escrow Holder shall be sent simultaneously to the other noticed parties pursuant to Section 8 herein (the “Notice Parties”).  If the Notice Parties do not object to the Notifying Party’s notice to the Escrow Holder within ten (10) days after the Notice Parties’ receipt of the Notifying Party’s certificate to the Escrow Holder, the Escrow Holder shall be able to rely on the same.  If the Notice Parties send, within such ten (10) days, written notice to the Escrow Holder disputing the Notifying Party’s certificate, a dispute shall exist, and the Escrow Holder shall hold the Deposit as hereinafter provided.  The parties hereto hereby acknowledge that Escrow Holder shall have no liability to any party on account of Escrow Holder’s failure to disburse the Deposit if a dispute shall have arisen with respect to the propriety of such disbursement and, in the event of any dispute as to who is entitled to receive the Escrow Holder, disburse them in accordance with the final order of a court of competent jurisdiction, or to deposit or interplead such funds into a court of competent jurisdiction pending a final decision of such controversy.  The parties hereto further agree that Escrow Holder shall not be liable for failure to any depository and shall not be otherwise liable except in the event of Escrow Holder’s gross negligence or willful misconduct.  The Escrow Holder shall be reimbursed on an equal basis by Purchaser and Seller for any reasonable expenses incurred by the Escrow Holder arising from a dispute with respect to the Deposit.  The obligations of Seller with respect to the Escrow Holder are intended to be binding only on Seller and Seller’s assets and shall not be personally binding upon, nor shall any resort be had to, the private properties of any of the partners, officers, directors, shareholders or beneficiaries of Seller, or of any partners, officers, directors, shareholders or beneficiaries of any partners of Seller, or of any of Seller’s employees or agents.

Page 21


9.2Seller’s Deliveries. Seller shall deliver either at the Closing or by making available at the Property, as appropriate, the following original documents, each executed and, if required, acknowledged:

9.2.1An Assignment and Assumption of Ground Lease, in the form attached hereto as Exhibit 9.2.1.

9.2.2Reserved;

9.2.3A Bill of Sale and Assignment and Assumption Agreement in the form attached hereto as Exhibit 9.2.3.

9.2.4The Ground Lease and all books and records at the Property held by or for the account of Seller, including, without limitation, plans and specifications, as available.

9.2.5Copies of all Contracts relating to the Property shown on Exhibit 1.1.5 which Purchaser has elected to assume or which are not terminable by Seller on or before the Closing Date.

9.2.6An affidavit pursuant to the Foreign Investment and Real Property Tax Act in the form attached hereto as Exhibit 9.2.6.

9.2.7An Owner’s Affidavit in substantially the form of Exhibit 3.6 attached hereto.

9.2.8Consent from Ground Lessor to the assignment of the Ground Lease by Seller to Purchaser on such form as Ground Lessor may require.

9.2.9A certificate in form reasonably acceptable to Purchaser restating and reaffirming Seller’s representations pursuant to Section 5.1 hereof, with such changes as shall be necessary to make such representations true, complete, and accurate in all material respects as of the date and time of Closing.

9.2.10Any other documents reasonably required by the Title Company in connection with the Closing.

9.3Purchaser’s Deliveries. At the Closing, Purchaser shall (i) pay Seller the Purchase Price; and (ii) execute the agreements referred to in Sections 9.2.1 and 9.2.3; and (iii) deliver such other documents as reasonably required by the Title Company in connection with the Closing.

9.4Possession. Purchaser shall be entitled to possession of the Property upon conclusion of the Closing, subject to the Ground Lease.

9.5Insurance. Seller shall terminate its policies of insurance as of noon on the Closing Date, and Purchaser shall be responsible for obtaining its own insurance thereafter.

Page 22


9.6Purchaser’s Conditions Precedent to Closing. Purchaser’s obligation to consummate the transaction contemplated by this Agreement will be subject to satisfaction or waiver of each of the following conditions (“Purchaser’s Closing Conditions Precedent”); provided, however, that Purchaser will have the unilateral right to waive any Purchaser’s Closing Condition Precedent, in whole or in part, by written notice received by Seller on or before the Closing Date:

(i)Representations and Warranties of Seller. The representations and warranties of Seller set forth in Section 5.1 hereof, will be true and correct in all material respects; provided, however, Seller shall not be in default hereunder if any such representations or warranties (which were true in all material respects when made) have become untrue in any material respect after the Effective Date due to any reason other than any act or omission of Seller in violation of the express terms of this Agreement.

(ii)Obligations of Seller. Seller will have performed all of the obligations required to be performed by Seller under this Agreement in all material respects.

(iii)Seller’s Closing Documents. Seller shall have executed and delivered all of the documents provided in Section 9.2 above.

(iv)Reserved.

(v)Ground Lessor Consent. Seller shall have delivered to Purchaser the consent from Ground Lessor to the assignment of the Ground Lease by Seller to Purchaser.

(vi)Ground Lease. The Ground Lease shall be in full force and effect and no defaults thereunder shall exist.

(vii)TAMU Approval. Purchaser shall have obtained the TAMU Approval prior to the TAMU Approval Deadline.

(viii)Title Policy. Title Company shall be irrevocably committed to issue the Owner’s Policy showing no exceptions other than the Permitted Encumbrances and containing such endorsements as Purchaser may require.

10.DEFAULT; FAILURE OF CONDITION.

10.1Purchaser Default. If Purchaser shall become in breach of or default in its Closing obligations under this Agreement, as Seller’s sole and exclusive remedy, the entire Deposit shall be retained by Seller as liquidated damages, and both parties shall be relieved of and released from any further liability hereunder except for the Surviving Obligations.  Seller and Purchaser agree that the amount of the Deposit is a fair and reasonable amount to be retained by Seller as agreed and liquidated damages in light of Seller’s removal of the Property from the market and the costs incurred by Seller and shall not constitute a penalty or a forfeiture.

Page 23


10.2Seller Default. If Seller shall refuse or fail to convey the Property as herein provided for any reason other than (a) a default by Purchaser or (b) any other provision of this Agreement which permits Seller to terminate this Agreement, Purchaser shall elect as its sole and exclusive remedy hereunder either to (i) terminate the Agreement and recover the Deposit, less the Independent Consideration, and Seller shall reimburse Purchaser for all of Purchaser’s Costs (as hereinafter defined), which reimbursement shall be paid within thirty (30) days following termination and Seller’s receipt of reasonable supporting information for the costs incurred, or; (ii) enforce specific performance and filing suit within the time period required under applicable law.  If the remedy if specific performance is not available as a result of Seller’s having conveyed the Property to another entity or encumbered the Property after the Effective Date, then Purchaser shall have all remedies at law or in equity without limitation. For the purposes of this Agreement, the term “Purchaser’s Costs” shall mean all third-party expenses incurred by Purchaser in connection with the Property and this Agreement related to: title examination, due diligence and third-party investigations, studies and reports related to the Property, and  reasonable attorneys’ fees incurred by Purchaser in connection the drafting and/or negotiating this Agreement and in connection with the conduct of due diligence by Purchaser; provided, however, that in no event shall Purchaser’s Costs exceed, in the aggregate, the sum of $50,000.

10.3Failure of Condition. In the event a condition to Closing is not satisfied and the reason for such failure of condition is not due to a breach or default by Seller or Purchaser, hereunder, then at the option of the party in whose favor such condition was given shall have the right to terminate this Agreement upon written notice to the other party, in which event the Deposit (less the independent consideration) will be returned to Purchaser and the parties shall have no further obligations under this Agreement except for the Surviving Obligations. If Seller breaches the terms of this Agreement, or if any representation or warranty of Seller contained in this Agreement or was untrue in any material respect when made or is untrue as of the Closing Date due to any act or omission by Seller in violation or breach of this Agreement, then subject to the last paragraph of Section 5.1, Seller shall be in default hereunder and Purchaser shall have the remedies set forth in Section 10.2 above.

11.MISCELLANEOUS.

11.1Entire Agreement. This Agreement, together with the Exhibits attached hereto, all of which are incorporated by reference, is the entire agreement between the parties with respect to the subject matter hereof, and no alteration, modification or interpretation hereof shall be binding unless in writing and signed by both parties.

11.2Severability; Construction. If any provision of this Agreement or application to any party or circumstances shall be determined by any court of competent jurisdiction to be invalid and unenforceable to any extent, the remainder of this Agreement or the application of such provision to such person or circumstances, other than those as to which it is so determined invalid or unenforceable, shall not be affected thereby, and each provision hereof shall be valid and shall be enforced to the fullest extent permitted by law.  All dollar amounts stated in this Agreement are U.S. dollar amounts. The normal rule of construction that any ambiguities be resolved against the

Page 24


drafting party shall not apply to the interpretation of this Agreement or any exhibits or amendments hereto.

11.3Applicable Law; Venue. This AGREEMENT and any claim, controversy or dispute arising under or related to this agreement, the relationship of the parties, and/or the interpretation and enforcement of the rights and duties of the parties will be governed by the laws of the State where the Property is located without regard to any conflicts of law principles.  THIS AGREEMENT IS PERFORMABLE IN AND EXCLUSIVE VENUE FOR ANY ACTION BROUGHT WITH RESPECT HERETO SHALL LIE IN THE STATE COURT FOR THE COUNTY IN WHICH THE LAND IS LOCATED, OR, IF APPLICABLE, THE UNITED STATES DISTRICT COURT FOR THE DISTRICT IN WHICH THE LAND IS LOCATED, WITHOUT REGARD TO CONFLICTS IN LAW.

11.4Assignability. Except for an assignment to an affiliate of Purchaser, which shall not require the consent of Seller, Purchaser may not assign this Agreement without first obtaining Seller’s written consent.  Any assignment in contravention of this provision shall be void.  No assignment shall release the Purchaser herein named from any obligation or liability under this Agreement.  Any assignee shall be deemed to have made any and all representations and warranties made by Purchaser hereunder, as if the assignee were the original signatory hereto.

11.5Successors Bound. This Agreement shall be binding upon and inure to the benefit of Purchaser and Seller and their respective successors and permitted assigns.

11.6Intentionally Omitted.

11.7No Public Disclosure. Neither Seller nor Purchaser will release or cause or permit to be released any press notices, or publicity or advertising promotion relating to, or otherwise announce or disclose or cause or permit to be announced or disclosed, in any manner whatsoever, the terms, conditions or substance of this Agreement without first obtaining the written consent of the other party; provided, however, that after Closing the foregoing agreement shall be binding on Seller and its Representatives (as defined below), but shall not be binding on Purchaser and its Representatives. The foregoing shall not preclude either party from discussing the substance or any relevant details of such transactions with any of its attorneys, accountants, professional consultants, lenders, partners, investors, or any prospective lender, partner or investor, as the case may be (each a Representative), or prevent either party hereto, from complying with laws, rules, regulations and court orders, including without limitation, governmental regulatory, disclosure, tax and reporting requirements or enforcing its rights under this Agreement. To the extent that Purchaser or any Representative of Purchaser is required to disclose any such confidential information by law, regulation or stock exchange rule or pursuant to a subpoena, court order or other legal proceeding, Purchaser shall notify Seller within one business day of its knowledge of such legally required disclosure. Purchaser shall cooperate with Seller’s counsel in any appeal or challenge to such disclosure made by Seller.  If no protective order or similar relief is obtained, Purchaser:  (i) may disclose only that portion of the confidential information that it is legally obligated to disclose, (ii) shall exercise reasonable efforts to obtain reliable assurances that the disclosed information will be kept confidential and (iii) shall exercise reasonable efforts to provide

Page 25


Seller with a copy of the information to be disclosed before the same is given to any third party.  Each party shall have the right to seek equitable relief, including without limitation injunctive relief or specific performance, against the other party in order to enforce the provisions of this Section 11.7. The provisions of this Section 11.7 shall survive Closing and any termination of this Agreement.

11.8Captions. The captions in this Agreement are inserted only as a matter of convenience and for reference and in no way define, limit or describe the scope of this Agreement or the scope or content of any of its provisions.

11.9Attorneys’ Fees. In the event of any litigation arising out of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees and costs.

11.10No Partnership. Nothing contained in this Agreement shall be construed to create a partnership or joint venture between the parties or their successors in interest.

11.11Time of Essence. Time is of the essence in this Agreement.

11.12Counterparts. This Agreement may be executed and delivered in any number of counterparts, each of which so executed and delivered shall be deemed to be an original and all of which shall constitute one and the same instrument. A fully executed PDF copy of this Agreement shall be effective as an original. An electronic signature of any party or parties hereto shall have the same force and effect as an original of such signature(s), and the parties hereto agree to be bound by any electronic signature(s) and by any electronic record of this Agreement executed or adopted with one or more electronic signatures, and hereby waive any defenses to the enforcement of the terms of this Agreement based on the form of signature.

11.13Recordation. Purchaser and Seller agree not to record this Agreement or any memorandum hereof.  The terms of this Section 11.13 shall survive any termination of this Agreement; provided, however, if Purchaser timely files a claim for specific performance of this Agreement, Purchaser shall have the right to execute and record a Lis Pendens related thereto.

11.14Proper Execution. The submission by Seller to Purchaser of this Agreement in unsigned form shall be deemed to be a submission solely for Purchaser’s consideration and not for acceptance and execution.  Such submission shall have no binding force and effect, shall not constitute an option, and shall not confer any rights upon Purchaser or impose any obligations upon Seller irrespective of any reliance thereon, change of position or partial performance.  The submission by Seller of this Agreement for execution by Purchaser and the actual execution and delivery thereof by Purchaser to Seller shall similarly have no binding force and effect on Seller unless and until Seller shall have executed this Agreement and the Deposit shall have been received by the Title Company and a counterpart thereof shall have been delivered to Purchaser.

11.15Calculation of Time Periods.  Unless otherwise specified, in computing any period of time described herein, the day of the act or event after which the designated period of time begins to run is not to be included and the last day of the period so computed is to be included at,

Page 26


unless such last day is a Saturday, Sunday or legal holiday for national banks in the location where the Property is located, in which event the period shall run until the end of the next day which is neither a Saturday, Sunday, or legal holiday.  The last day of any period of time described herein shall be deemed to end at 5:00 p.m. Central time.

11.16Section 1031 Exchange. Either party may consummate the purchase or sale (as applicable) of the Property as part of a so-called like kind exchange (an “Exchange”) pursuant to § 1031 of the Code, provided that:  (a) the Closing shall not be delayed or affected by reason of the Exchange nor shall the consummation or accomplishment of an Exchange be a condition precedent or condition subsequent to the exchanging party’s obligations under this Agreement, (b) the exchanging party shall effect its Exchange through an assignment of this Agreement, or its rights under this Agreement, to a qualified intermediary, (c) neither party shall be required to take an assignment of the purchase agreement for the relinquished or replacement property or be required to acquire or hold title to any real property for purposes of consummating an Exchange desired by the other party; and (d) the exchanging party shall pay any additional costs that would not otherwise have been incurred by the non-exchanging party had the exchanging party not consummated the transaction through an Exchange (such payment obligation shall survive Closing or any termination of this Agreement).  Neither party shall by this Agreement or acquiescence to an Exchange desired by the other party have its rights under this Agreement affected or diminished in any manner or be responsible for compliance with or be deemed to have warranted to the exchanging party that its Exchange in fact complies with § 1031 of the Code.

11.17Limitation of Liability. Purchaser hereby acknowledges and agrees that in no event shall any partner, member, manager, shareholder, or officer of Seller ever be liable to Purchaser as a result of a breach of this Agreement, and Purchaser agrees to look solely to Seller and to the rents, issues and profits from the Property for satisfaction of any claim, loss or damage.  Seller hereby acknowledges and agrees that in no event shall any partner, member, manager, shareholder, or officer of Purchaser ever be liable to Seller as a result of a breach of this Agreement. The provisions of this Section 11.17 shall survive Closing or any termination of this Agreement.

11.18Jury Waiver. PURCHASER AND SELLER DO HEREBY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVE THEIR RIGHT TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION BASED HEREON, OR ARISING OUT OF, OR UNDER OR IN CONNECTION WITH THIS AGREEMENT, THE DOCUMENTS DELIVERED BY PURCHASER AT CLOSING OR SELLER AT CLOSING, OR ANY COURSE OF CONDUCT, COURSE OF DEALINGS, STATEMENTS (WHETHER VERBAL OR WRITTEN) OR ANY ACTIONS OF EITHER PARTY ARISING OUT OF OR RELATED IN ANY MANNER WITH THIS AGREEMENT OR THE PROPERTY (INCLUDING WITHOUT LIMITATION, ANY ACTION TO RESCIND OR CANCEL THIS AGREEMENT AND ANY CLAIMS OR DEFENSES ASSERTING THAT THIS AGREEMENT WAS FRAUDULENTLY INDUCED OR IS OTHERWISE VOID OR VOIDABLE).  THIS WAIVER IS A MATERIAL INDUCEMENT FOR SELLER TO ENTER INTO AND ACCEPT THIS AGREEMENT AND THE DOCUMENTS DELIVERED BY PURCHASER AT CLOSING AND SHALL SURVIVE THE CLOSING OF TERMINATION OF THIS AGREEMENT.

Page 27


11.19Merger Provision.  Except as otherwise expressly provided herein, any and all rights of action of Purchaser for any breach by Seller of any representation, warranty or covenant contained in this Agreement shall merge with the instruments executed at Closing, shall terminate at Closing and shall not survive Closing.

11.20Further Assurances. Before and after Closing, Purchaser and Seller shall execute and deliver to the other party all such documents that such other party may reasonably require to effect, confirm or otherwise perfect the transfer of property and other covenants and agreements of the parties contemplated by this Agreement. The provisions of this Section 11.20 shall survive Closing.

[Remainder of page intentionally left blank; Signatures begin on following page]

Page 28


IN WITNESS WHEREOF, Purchaser and Seller have executed this Agreement on the date set forth below, effective as of the Effective Date.

SELLER:

IBIO CDMO LLC,

a Delaware limited liability company

By:

/s/ Martin Brenner

Name:

Martin Brenner

Title:

Authorized Person

PURCHASER:

MAJESTIC REALTY CO.,

a California corporation

By:

/s/ Edward P. Roski, Jr.

Name:

Edward P. Roski, Jr.

Title:

President and Chairman of the Board

Signature Page


TITLE COMPANY JOINDER

By execution hereof, the Title Company hereby covenants and agrees to be bound by the terms of this Agreement.

CHICAGO TITLE – COMMERCIAL

By:

/s/ Nko Justin

Name:

Nko Justin

Title:

Senior Escrow Officer

Signature Page


EXHIBIT 1.1.1

LEGAL DESCRIPTION

LEASEHOLD ESTATE in the following as created by Ground Lease Agreement executed by and between The Board of Regents of The Texas A&M University System, as Landlord, and Texas Bioproperties, LP, as Tenant, as evidenced by Memorandum of Lease dated March 08, 2010, filed March 15, 2010, recorded in Volume 9536, Page 255, Real Property Records, Brazos County, Texas, as assigned to College Station Investors LLC, by and thru Special Warranty Deed and Assignment of Ground Lease dated December 22, 2015, filed December 22, 2015, recorded under Clerk's File No. 2015- 1251621, Real Property Records, Brazos County, Texas:

All that certain lot, tract or parcel of land being 21.401 acres situated in the J.H. Jones Survey, Abstract No. 26, Brazos County, Texas, and being all of that certain called 21.401 acre tract as described in Memorandum of Lease between The Board of Regents of The Texas A&M University System and TEXAS BIOPROPERTIES, LP, as recorded in Volume 9536, Page 255 of the Official Records of Brazos County, Texas, said 21.401 acre tract being more particularly described by metes and bounds as follows:

BEGINNING at a 1/2” Iron Rod with Cap found in the southwest right-of-way line of South Traditions Drive as described in Volume 9267, Page 132 for the most northerly corner, said corner being the most easterly corner of the Texas A&M University System called 198.0559 acre tract as described in Volume 7988, Page 209; THENCE S 51° 09'57” E, along the southerly Right-of-Way line of said South Traditions Drive a distance of 125.17 feet to a 1/2” Iron Rod with Cap found for point of curvature;

THENCE continuing along the southerly Right-of-Way line of said South Traditions Drive around a curve in a counterclockwise direction having a delta angle of 40° 38'12”, an arc distance of 425.55 feet, a radius of 600.00 feet, and a chord of S 71° 29’03” E, a distance of 416.68 feet to a 1/2” Iron Rod with Cap found for the northeast corner;

THENCE S 1° 48’09” E, a distance of 221.86 feet to a 1/2” Iron Rod with Cap found for angle point;

THENCE S 48° 08’12” E, a distance of 429.28 feet to a 1/2” Iron Rod with Cap found for the most easterly corner, said corner being located in the southeast City of Bryan City Limits Line as per deed described in Volume 3481, Page 81, said corner also being located in the northwest Right-of-Way line of HSC Parkway;

THENCE S 41° 51’48” W, along the City Limits Line a distance of 464.43 feet to a 1/2” Iron Rod with Cap found for a point of curvature;

THENCE around a curve in a clockwise direction having a delta angle of 31° 10’07”, an arc distance of 401.19 feet, a radius of 737.50 feet, and a chord of S 57° 26’51” W, a distance of 396.27 feet to a 1/2” Iron Rod with Cap found for the most southerly corner;

THENCE N 47° 19’28” W, a distance of 981.81 feet to a 1/2” Iron Rod with Cap found in the southeast line of said called 198.0559 acre tract, a 1/2” Iron Rod with Cap found for the

Page 1


most southerly corner of said called 198.0559 Acre Tract bears S 41°44’03” W a distance of 1412.75 feet;

THENCE N 41°44’03” E, along the southeast line of said called 198.0559 acre tract a distance of 820.96 feet to the PLACE OF BEGINNING AND CONTAINING AN AREA OF 21.401 ACRES OF LAND MORE OR LESS.

Page 2


EXHIBIT 3.1.2

INSURANCE REQUIREMENTS

Prior to performing Inspections at the Property, Purchaser and Purchaser’s consultant and/or contractor and any subcontractor thereof (and other agent, contractor or consultant of Purchaser performing activities) shall have and maintain insurance coverage in form and substance reasonably acceptable to Seller complying with the requirements set forth below.

A.

Required Types of Insurance Coverage

1.

Workers’ Compensation and Employers’ Liability

a.

Statutory Worker’s Compensation insurance as required by law.

b.

Employers’ Liability insurance with limits of at least $1,000,000 per occurrence.

2.

General Liability Insurance

a.

Commercial General Liability policy form on an occurrence basis including Premises/Operations Liability, Contractual Liability (which shall include coverage for, but shall not limit, Purchaser’s indemnification obligations hereunder), Independent Contractors Coverage and Products/Completed Operations Liability with the explosion, collapse and underground (XCU) exclusions eliminated.

b.

Limits of Liability: Five Million Dollars ($5,000,000) combined single limit for Bodily Injury and Property Damage coverage. Limits of Liability may be provided under a Commercial General Liability and Umbrella Liability Policy, if desired.

B.

Additional Requirements

1.

Except where prohibited by law, all insurance policies shall contain provisions that the insurance companies waive the rights of recovery or subrogation against Seller, Seller’s agents and employees, and their insurers.

2.

Such insurance shall not be subject to cancellation except upon thirty (30) days’ prior written notice to Seller.

3.

All insurance required hereunder shall be with insurance companies which (i) are rated by Best’s Insurance Reports, (ii) have a rating of at least A-(VIII) and (iii) are licensed to do business in the state where the property is located. Prior to commencement of the performance of the Inspections, Purchaser shall deliver to Seller certificates of insurance evidencing the coverages required hereunder or such other evidence of compliance with the foregoing insurance requirements as is required by, and

Page 1


satisfactory and acceptable to, Seller.

4.

The following parties shall be named as additional insureds on ISO Form CG 20 26 under the Commercial General Liability, Automobile Liability (if any) and Umbrella Liability insurance policies required to be maintained by Purchaser and Purchaser’s consultant and/or any subcontractor thereof:

iBio, Inc.

11750 Sorrento Valley Road, Suite 200

San Diego, CA 92121

Attn: Felipe Duran, CFO

Email: felipe.duran@ibioinc.com

With Copy to: legal@ibioinc.com

The Texas A&M University System

301 Tarrow, 6th Floor

College Station, Texas 77840—7896

Attention: Office of General Counsel

5.

All Commercial General Liability and Umbrella Liability policies maintained by Purchaser and Purchaser’s consultant and/or any subcontractor thereof shall contain a cross-liability provision and shall provide primary coverage as to Seller, and any other insurance available to Seller shall be noncontributing therewith.

Page 2


EXHIBIT 1.1.6

SCHEDULE OF CONTRACTS

[***]

Page 1


EXHIBIT 3.5.2(i)

LEGAL DESCRIPTION OF TAMU PURCHASE TRACT

All that certain lot, tract or parcel of land being 21.401 acres situated in the J.H. Jones Survey, Abstract No. 26, Brazos County, Texas, and being all of that certain called 21.401 acre tract as described in Memorandum of Lease between The Board of Regents of The Texas A&M University System and TEXAS BIOPROPERTIES, LP, as recorded in Volume 9536, Page 255 of the Official Records of Brazos County, Texas, said 21.401 acre tract being more particularly described by metes and bounds as follows:

BEGINNING at a 1/2” Iron Rod with Cap found in the southwest right-of-way line of South Traditions Drive as described in Volume 9267, Page 132 for the most northerly corner, said corner being the most easterly corner of the Texas A&M University System called 198.0559 acre tract as described in Volume 7988, Page 209; THENCE S 51° 09’57” E, along the southerly Right-of-Way line of said South Traditions Drive a distance of 125.17 feet to a 1/2” Iron Rod with Cap found for point of curvature;

THENCE continuing along the southerly Right-of-Way line of said South Traditions Drive around a curve in a counterclockwise direction having a delta angle of 40° 38’12”, an arc distance 425.55 feet, a radius of 600.00 feet, and a chord of S 71° 29’03” E, a distance of 416.68 feet to a 1/2” Iron Rod with Cap found for the northeast corner;

THENCE S 1° 48’09” E, a distance of 221.86 feet to a 1/2” Iron Rod with Cap found for angle point;

THENCE S 48° 08’12” E, a distance of 429.28 feet to a 1/2” Iron Rod with Cap found for the most easterly corner, said corner being located in the southeast City of Bryan City Limits Line as per deed described in Volume 3481, Page 81, said corner also being located in the northwest Right-of-Way line of HSC Parkway;

THENCE S 41° 51’48” W, along the City Limits Line a distance of 464.43 feet to a 1/2” Iron Rod with Cap found for point of curvature;

THENCE around a curve in a clockwise direction having a delta angle of 31° 10’07”, an arc distance of 401.19 feet, a radius of 737.50 feet, and a chord of S 57° 26’51” W, a distance of 396.27 feet to a 1/2” Iron Rod with Cap found for the most southerly corner;

THENCE S 47° 19’28” W, a distance of 981.81 feet to a 1/2” Iron Rod with Cap found in the southeast line of said called 198.0559 acre tract, a 1/2” Iron Rod with Cap found for most southerly corner of said called 198.0559 Acre Tract bears S 41° 44’03” W a distance of 1412.75 feet;

THENCE S 41° 44’03” E, along the southeast line of said called 198.0559 acre tract a distance of 820.96 feet to the PLACE OF BEGINNING AND CONTAINING AN AREA OF 21.401 ACRES OF LAND MORE OR LESS.

Page 1


EXHIBIT 3.5.2(ii)

DEPICTION OF TAMU PURCHASE TRACT

Graphic

Page 2


EXHIBIT 3.6

FORM OF OWNER’S AFFIDAVIT

STATE OF TEXAS

§

§

COUNTY OF ________

§

BEFORE ME, the undersigned authority, on this day personally appeared ___________________, as _________________ of ___________, a ____________ (“Owner”) who on his oath, deposes and says, to the best of his knowledge and belief, as follows:

1.

Affiant is a duly authorized representative of Owner and in that capacity, is authorized to act on behalf of Owner in all matters relating to the sale, disposition and financing of the ground lease estate identified on Exhibit A attached hereto (hereinafter the “Property”).

2.

Owner is desirous of selling the Property and, in connection therewith, ____________________________(the “Title Company”) has issued its Title Commitment No. _________dated ____________, 2021 covering the Property (the “Title Commitment”).

3.

In connection with the issuance of the owner’s policy at Closing pursuant to the Title Commitment, Affiant makes the following statement of facts:

a.Affiant has no knowledge of any adverse claim to any of the Property; and that so far as Affiant knows there are no encroachments or boundary conflicts other than those shown on the Title Commitment and/or the survey of the Property dated ____________ (the “Survey”), a copy of which has been delivered to and reviewed by the Title Company.

b.Except as may be disclosed in the Title Commitment, Affiant states (i) Owner has not incurred any indebtedness that would affect the title to the Property, (ii) to Affiant’s knowledge, there are no liens (including Federal or States Liens, Judgment Liens or materialman’s and mechanic’s liens) of any kind on the Property and (iii) to Affiant’s knowledge, no suits pending against the Owner in Federal or State Court except as may be disclosed in the Title Commitment.

c.Except as shown on the Title Commitment or the Survey (i) no person or entity now has possession of the Property, (ii) Affiant has no current and actual knowledge of any person or entity that would have the right to possession of the Property other than Owner and other than as may be disclosed in said Title Commitment or Survey and (iii) Owner has not granted any options to purchase or rights of first refusal to purchase the Property.

d.Except for obligations incurred for routine and ordinary maintenance of the Property, during the past 150 days no materials have been delivered and no work has been performed on the Property, and all labor and material used in the construction of improvements on the Property have

Page 1


been paid, and there are no unpaid labor or material claims against the improvements or the Property upon which same are situated. Owner has not previously conveyed the Property and is not a debtor in bankruptcy.

4.

Affiant recognizes that but for the making of the hereinabove statement of facts relative to the Property, the Title Company would not issue its Title Policy with respect to the Property and that such statements have been made as a material inducement for the issuance of such Policy.

Further affiant sayeth not.

WITNESS, my hand this ___ day of ______________, 2023.

AFFIANT:

By:

Name:

Title:

SWORN TO AND SUBSCRIBED BEFORE ME, this ___ day of _______________, 2023 by ________________________, the __________________, a ______________, on behalf of said _______________________.

Notary Public, State of

[NOTARIAL SEAL]

[Signature Page to Affidavit as to Debts and Liens]

Page 2


EXHIBIT 9.2.1

FORM OF ASSIGNMENT AND ASSUMPTION OF GROUND LEASE

THIS ASSIGNMENT AND ASSUMPTION OF GROUND LEASE (this “Assignment of Ground Lease”) is made as of the ____ day of ___________, 2023 for valuable consideration, the receipt and sufficiency of which are hereby acknowledged, by and between ______________________ (collectively, “Assignor”), and __________________________(“Assignee”).

WITNESSETH:

For good and valuable consideration, receipt and sufficiency of which are hereby acknowledged, Assignor and Assignee hereby agree as follows:

Assignor hereby sells, transfers, assigns and conveys to Assignee all right, title and interest of Assignor in and to that certain ground lease described on Exhibit B attached hereto and made a part hereof (the “Ground Lease”), relating to the land and improvements located in the County of Brazos, State of Texas (the “Real Property”), as more particularly described in Exhibit A hereto and made a part hereof and all of the rights, interests, benefits and privileges of the lessee thereunder, including without limitation Seller’s leasehold interest in the improvements located on the Real Property and all of Assignor’s assignable and transferable right, title, and interest (if any) in and to all easements, hereditaments, and appurtenances belonging to or inuring to the benefit of Seller and pertaining to the Real Property, if any.

This Assignment of Ground Lease is given pursuant to that certain Purchase and Sale Agreement dated as of _______________, 2023, between Assignor and Assignee.

Assignee hereby accepts the assignment of the Ground Lease and agrees to assume and discharge, in accordance with the terms hereof, all of the obligations thereunder from and after the date hereof.

If any litigation between Assignor and Assignee arises out of the obligations of the parties under this agreement or concerning the meaning or interpretation of any provision contained herein, the non-prevailing party shall pay the prevailing party’s costs and expenses of such litigation, including, without limitation, reasonable attorneys’ fees.

This Assignment of Ground Lease may be executed in any number of counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same instrument.

Page 1


IN WITNESS WHEREOF, the parties hereto have executed this Assignment of Ground Lease as of the date first above written.

ASSIGNOR:

By:

Name:

Title:

STATE OF TEXAS

§

§

COUNTY OF__________

§

This instrument was acknowledged before me on ___________________, 2022 by _________________________________, _______________________ of _______________________, a _________________________ on behalf of said _______________________.

Notary Public, State of Texas

My Commission Expires:

Page 2


ASSIGNEE:

By:

Name:

Title:

STATE OF__________

§

§

COUNTY OF__________

§

This instrument was acknowledged before me on ________________, 2023, by _______________________________, ________________ of ________________, a ___________________ on behalf of said ________________________.

Notary Public, State of Texas

My Commission Expires:

Page 3


EXHIBIT A

To Assignment and Assumption of Ground Lease

PROPERTY DESCRIPTION

Page 4


EXHIBIT B

To Assignment and Assumption of Ground Lease

DESCRIPTION OF GROUND LEASE

Page 5


EXHIBIT 9.2.3

BILL OF SALE AND ASSIGNMENT AND ASSUMPTION AGREEMENT

THIS BILL OF SALE AND ASSIGNMENT AND ASSUMPTION AGREEMENT (this “Bill of Sale and Assignment”) is made _______  ___, 2023 (the “Effective Date”), by _________________________, a __________________ (“Grantor”), to ___________________________, a ____________________ (“Grantee”).

A.Grantor, as Seller, and Grantee, as Purchaser, entered into that certain Purchase and Sale Agreement (the “Agreement”) with an Effective Date of _________, 2023, for the purchase and sale of the leasehold estate arising under that certain Ground Lease covering the land located in Brazos County, Texas described on Exhibit A attached hereto (the “Land”).

B.In connection with the conveyance of the leasehold estate in the Land arising under the Ground Lease, Grantor agreed to execute and deliver this Bill of Sale and Assignment pursuant to the Agreement.

C.All capitalized terms used in this Bill of Sale and Assignment without separate definition shall have the same meanings assigned to them in the Agreement.

NOW, THEREFORE, for good and valuable consideration, the receipt and adequacy of which are hereby acknowledged and confessed, Grantor hereby transfers, conveys, sells, assigns and sets over to Grantee:

1.All of Grantor’s assignable and transferable right, title, and interest in and to improvements, furniture, personal property, machinery, apparatus, and equipment owned by Grantor and currently used in the operation, repair and maintenance of the Property described on Exhibit B attacand situated thereon (collectively, the “Personal Property”);

2.The Contracts described on Exhibit B attached hereto and relating to the Property (collectively, the “Contracts”).

11.20.13.To the extent not proprietary and without representation as to whether third party consent is required, and at no cost or liability to Grantor, all of Grantor’s assignable and transferable right, title, and interest (if any) in and to all intangible assets of any nature relating to any or all of the Land, the Improvements and the Personal Property, including, but not limited to, (i) all guaranties and warranties issued with respect to the Personal Property or the Improvements (if any) including equipment and construction warranties and the roof warranty; (ii) all plans and specifications, drawings and prints describing the Improvements; (iii) trademarks or trade names associated with the Improvements; (iv) all development rights; (v) any governmental permits, entitlements, approvals, licenses and certificates (including any pending applications) including without limitation, those pertaining to zoning, use, occupancy, and signage for the Property; and (vi) all rights and claims of Grantor against third parties related to the Property (collectively, the “Intangibles”).


Grantee hereby assumes and accepts the conveyance and assignment of the Contracts and Intangibles as aforesaid to the extent arising from and after the date hereof.

If any litigation between Grantee and Grantor arises out of the obligations of the parties under this agreement or concerning the meaning or interpretation of any provision contained herein, the non-prevailing party shall pay the prevailing party’s costs and expenses of such litigation, including, without limitation, reasonable attorneys’ fees.

This agreement may be executed and delivered in any number of counterparts, each of which so executed and delivered shall be deemed to be an original and all of which shall constitute one and the same instrument.

IN WITNESS WHEREOF, Grantor and Grantee have executed this agreement as of​ ​​ ​​ ​, 2023.

GRANTOR:

____________________________________________________,a

By:

Name:

Title:

GRANTEE:

____________________________________________________,a

By:

Name:

Title:


EXHIBIT 9.2.6

FIRPTA AFFIDAVIT

FIRPTA CERTIFICATION UNDER SECTION 1445 I.R.C

Section 1445 of the Internal Revenue Code of 1986, as amended, provides that a transferee of a U.S. real property interest must withhold tax if the transferor is a foreign person. For U.S. tax purposes (including Section 1445), the owner of a disregarded entity (which has legal title to a U.S. real property interest under local law) will be the transferor of the property and not the disregarded entity.  To inform the transferee that withholding of tax is not required upon the disposition of a U.S. real property interest by IBIO CDMO LLC, a Delaware limited liability company (“Transferor”), Transferor hereby certifies to [______________________], a Delaware limited liability company:

1. The Company is not a foreign corporation, foreign partnership, foreign person, foreign trust, or foreign estate (as those terms are defined in the Internal Revenue Code and Income Tax Regulations);

2. The Company is not a disregarded entity as defined in §1.1445-2(b)(2)(iii);

3. The Company’s U.S. employer identification number is 81-0925839; and

4. The Company’s office address is:

iBio, Inc.

11750 Sorrento Valley Road, Suite 200

San Diego, CA 92121

The Company understands that this certification may be disclosed to the Internal Revenue Service by transferee and that any false statement contained herein could be punished by fine, imprisonment, or both.

Under penalties of perjury, the Company declares that the Company has examined this certification and to the best of the Company’s knowledge and belief it is true, correct, and complete, and the Company further declares that the Company has authority to sign this document.

[SIGNATURE ON FOLLOWING PAGE]


Dated:  ______________, 2023.

IBIO CDMO LLC,

a Delaware limited liability company

By:

Name:

Title:


Exhibit 10.2

SIXTH AMENDMENT TO CREDIT AGREEMENT

THIS SIXTH AMENDMENT TO CREDIT AGREEMENT (this “Sixth Amendment”) is entered into as of the Sixth Amendment Closing Date (as defined below) by and between IBIO CDMO LLC, a Delaware limited liability company (“Borrower”), and WOODFOREST NATIONAL BANK, a national banking association, as lender (in such capacity, “Lender”).

RECITALS

A.Borrower and Lender entered into that certain Credit Agreement dated November 1, 2021 (as amended by the First Amendment thereto dated as of October 11, 2022, the Second Amendment thereto dated as of February 9, 2023, the Third Amendment thereto dated as of February 20, 2023, the Fourth Amendment thereto dated as of March 24, 2023, the Fifth Amendment thereto dated as of May 10, 2023 and as otherwise amended, restated, supplemented or modified from time to time, the “Credit Agreement”).

B.Reference is made to that certain Purchase and Sale Agreement (the “Purchase Agreement”) dated as of September 15, 2023 by and between a third party, as buyer (“Buyer”), and Borrower, as seller, and joined by the title company named therein, regarding the sale of the iBio Property.

C.In connection with the Purchase Agreement, Borrower has requested Lender to enter into certain agreements and amendments to certain provisions of the Credit Agreement.

D.Borrower and Lender are willing to enter into the requested agreements and amendments set forth herein, subject to and conditioned upon the terms and conditions set forth in this Sixth Amendment.

AGREEMENT

NOW, THEREFORE, in consideration of the promises herein contained, the mutual benefits to be derived herefrom and other good and valuable consideration received by each party, and each intending to be legally bound hereby, the parties agree as follows:

I.Agreements and Amendments to Credit Agreement. Borrower and Lender agree as follows:

(a)Section 1.1, Definitions, of the Credit Agreement is hereby amended by adding the following definitions in their proper alphabetical order:

Sixth Amendment” means the Sixth Amendment to Credit Agreement dated as of the Sixth Amendment Closing Date by and between Borrower and Lender.

Sixth Amendment Closing Date” means September 18, 2023.

(b)Section 1.1, Definitions, of the Credit Agreement is hereby amended by replacing the definition of “Maturity Date” in its entirety to read as follows:


Maturity Date means the earlier of (a) December 31, 2023, or (b) the acceleration of maturity of the Term Loan in accordance with Section 12 of this Agreement.

(c)Section 8.1, Items to be Furnished, of the Credit Agreement is hereby amended, solely for the fiscal year ending June 30, 2023, by amending and restating sub clause (a)(i) of such section in its entirety to read as follows:

(a)(i) Annual Financial Statements. No later than 120 days after the last day of each fiscal year of Parent Guarantor, the audited balance sheet and related statements of income, retained earnings, and cash flows of Parent Guarantor and its Subsidiaries (including Borrower), showing the consolidated financial condition and results of operations of Parent Guarantor and its Subsidiaries (including Borrower) as of the end of and for such fiscal year, in each case setting out in comparative form the figures for the previous fiscal year, all reported on by a firm of independent certified public accountants of recognized national or regional standing and accompanied by a report from such independent certified public accountants confirming that such consolidated financial statements were prepared in accordance with GAAP consistently applied and present fairly, in all material respects, the consolidated financial condition and results of operations of Parent Guarantor and its Subsidiaries; provided that Borrower shall furnish, or cause to be furnished, to Lender, together with the foregoing deliveries, the statements of income of Borrower as of the end of and for such fiscal year, in Proper Form.

(d)Sale of iBio Property.

(i) Borrower shall deliver to Lender, within one Business Day of entry into or having knowledge thereof, any amendments or supplements to the Purchase Agreement, any material notices sent or received in respect thereof, any extension of the Closing Date (as defined in the Purchase Agreement) thereof or any terminations thereof.  Upon the reasonable written request of Lender, Borrower shall provide Lender with copies of any other documents directly related to the sale of the iBio Property.

(ii) Further to the foregoing, in order for Lender and Borrower to take all necessary steps to prepare for and consummate Payment in Full, upon the written request of Lender, Borrower shall deliver to Lender a copy of the applicable settlement statement with respect to the Purchase Agreement, such settlement statement, together with applicable payment steps and mechanics, to be satisfactory to Lender with respect to any Net Proceeds to be paid to Lender from the final closing and funding of the Purchase Agreement.

(iii) To the extent Borrower and Buyer request that Lender release its Liens securing the Obligations and terminate the Security Documents prior to Payment

2


in Full in order to facilitate the final closing and funding of the Purchase Agreement, Lender may, in its sole and absolute discretion, require such Persons, the Title Company (as defined in the Purchase Agreement) and any other applicable Person to enter into an escrow agreement or such other written agreement, in Proper Form, to affirm, confirm, protect and otherwise guarantee the payment to Lender of any and all applicable Net Proceeds received by Borrower, or by such Title Company on behalf of Borrower, from the final closing and funding of the Purchase Agreement.  For avoidance of doubt, notwithstanding the foregoing, Lender will not agree to release its Liens to the extent that such Net Proceeds are not sufficient to achieve Payment in Full, unless otherwise agreed by Lender pursuant to documentation satisfactory to Lender in its sole and absolute discretion.

(e)Appraisal.  If the final closing and funding of the Purchase Agreement does not occur on or before December 1, 2023, together with satisfaction of Payment in Full as set forth in clause (f)(ii) below within one (1) Business Day after such final closing and funding of the Purchase Agreement, and notwithstanding any limitations or restrictions set forth in Sections 8.3(b), 8.3(c) and 8.16(b) of the Credit Agreement, Borrower will permit, and will cause each Loan Party to permit, Representatives of Lender to obtain, or Borrower will otherwise, at the direction of Lender, obtain, as soon as possible after failure to satisfy such foregoing conditions, an appraisal of Borrower’s real estate, including the iBio Property, in Proper Form, all at the cost and expense of Borrower.

(f)Fee.  In addition to the fee set forth in Section I(e) of the Fifth Amendment, if the final closing and funding of the Purchase Agreement does not occur on or before December 1, 2023, together with satisfaction of Payment in Full as set forth in clause (f)(ii) below within one (1) Business Day after such final closing and funding of the Purchase Agreement, then Borrower shall pay to Lender a fee in the amount of $20,000 in immediately available funds on the earlier of (i) the date of the closing of the Purchase Agreement or (ii) the Maturity Date, such fee to be fully earned immediately upon Borrower’s failure to satisfy such foregoing conditions; provided that, notwithstanding the foregoing, such fee will not be due and payable and will be of no force and effect to the extent that such foregoing conditions are otherwise satisfied.

(g)Payment in Full.  Notwithstanding anything to contrary, within one (1) Business Day upon receipt thereof, Borrower shall, or Borrower shall cause and otherwise instruct the Title Company facilitating the final closing and funding of the Purchase Agreement to, apply to the outstanding balance of the Obligations, in accordance with Lender’s payment instructions, (i) all Net Proceeds (to the extent such Net Proceeds are not in an amount sufficient to achieve Payment in Full) or (ii) all necessary Net Proceeds (to extent such Net Proceeds are in excess of the amount necessary to achieve Payment in Full) in order to achieve Payment in Full, in either case, as applicable, received by Borrower, or by such Title Company on behalf of Borrower, from the final closing and funding of the Purchase Agreement.  For the avoidance of doubt, so long as Borrower provides reasonable notice to Lender of a payoff, Lender shall, at least one Business Day prior to the date Payment in Full occurs, provide

3


Borrower with a written payoff letter, and Borrower may at its election provide such payoff letter to such Title Company in order to facilitate all necessary disbursements to Lender, which payoff letter shall, among other things, contain an itemized break down of all outstanding Obligations to be paid on the date that Payment in Full occurs.

II.Conditions Precedent to the Effectiveness of Sixth Amendment.  This Sixth Amendment shall be effective upon the satisfaction of the following conditions precedent:

(a)Lender shall have received this Sixth Amendment duly executed by Borrower and Parent Guarantor;

(b)Lender shall have received an Officer’s Certificate and authorizing consent for each of Borrower and Parent Guarantor, in Proper Form;

(c)Lender shall have received an executed copy of the Purchase Agreement duly executed by Buyer and Borrower;

(d)To the extent outstanding and unpaid, the Borrower shall have paid to Lender (i) any fees and expenses due and owing under the Credit Agreement and (ii) all costs and expenses, including reasonable legal fees, payable in connection with this Sixth Amendment to the extent invoiced on or prior to the Sixth Amendment Closing Date; and

(e)No Potential Default or Default shall have occurred and be continuing.

III.Reaffirmation of Representations and Warranties.  To induce Lender to enter into this Sixth Amendment, Borrower hereby reaffirms, as of the Sixth Amendment Closing Date (except as otherwise provided herein or to the extent such representations and warranties speak as to an earlier date or a date certain), its representations and warranties contained in Section 7 of the Credit Agreement (other than the representation set forth in the last sentence of Section 7.10 of the Credit Agreement), and in all other documents executed pursuant thereto, and additionally represents and warrants as follows:

(a)The execution and delivery of this Sixth Amendment and the performance by Borrower of its obligations under this Sixth Amendment are within Borrower’s power, have been duly authorized by all necessary company action, have received all necessary governmental approval (if any shall be required), and do not and will not contravene or conflict with any provision of law or of the Organizational Documents of Borrower or of any agreement binding upon Borrower.

(b)This Sixth Amendment represents the legal, valid and binding obligations of Borrower enforceable against Borrower in accordance with its terms subject as to enforcement only to bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforcement of creditors’ rights generally.

(c)No change, event or state of affairs has occurred and is continuing which would constitute a Potential Default or a Default.

4


(d) No exhibit or schedule to the Credit Agreement is required to be supplemented, amended or modified in connection with the transactions contemplated by this Sixth Amendment.

IV.Defined Terms.  Terms used herein that are defined in the Credit Agreement, as amended hereby, shall have the same meanings herein, unless the context otherwise requires.

V.Reaffirmation of Credit Agreement.  This Sixth Amendment shall be deemed to be an amendment to the Credit Agreement, and the Credit Agreement, as amended hereby, is hereby ratified, adopted and confirmed in each and every respect.

VI.Ratification of Liens; Release. The Borrower acknowledges and ratifies, as of the Sixth Amendment Closing Date, the existence and priority of the Liens granted by the Borrower in favor of Lender pursuant to the Security Documents in and to the Collateral and represents, warrants and covenants that such Liens are valid, existing and in full force and effect.  THE BORROWER HEREBY RELEASES, DISCHARGES AND ACQUITS LENDER FROM ANY AND ALL CLAIMS, DEMANDS, ACTIONS, CAUSES OF ACTION, REMEDIES, AND LIABILITIES OF EVERY KIND OR NATURE (INCLUDING WITHOUT LIMITATION, LENDER LIABILITY) ARISING OUT OF ANY ACT, OCCURRENCE, TRANSACTION OR OMISSION OCCURRING IN CONNECTION WITH THE CREDIT AGREEMENT AND THE OTHER LOAN DOCUMENTS PRIOR TO THE SIXTH AMENDMENT CLOSING DATE.

VII.Governing Law.  THIS SIXTH AMENDMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF TEXAS.

VIII.Invalid Provisions.  If any provision of this Sixth Amendment is held to be illegal, invalid or unenforceable, (a) the legality, validity and enforceability of the remaining provisions of this Sixth Amendment shall not be affected or impaired thereby and (b) the parties shall engage in good faith negotiations to replace the illegal, invalid or unenforceable provisions, with valid provisions the economic effect of which comes as close as possible to that of the illegal, invalid or unenforceable provisions.  The invalidity of a provision in a particular jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

IX.Multiple Counterparts and Electronic Signatures.  This Sixth Amendment may be executed in any number of counterparts with the same effect as if all signatories had signed the same document.  All counterparts must be construed together to constitute one and the same instrument.  This Sixth Amendment may be transmitted and signed by facsimile, portable document format (PDF), or other electronic means, and shall have the same effect as manually-signed originals and shall be binding on the Loan Parties and Lender, with originals signatures to be delivered to Lender at Lender’s request.

X.Section Headings.  Section headings in this Sixth Amendment are included for convenience of reference only and shall not affect the interpretation of this Sixth Amendment.

XI.Successors and Assigns.  This Sixth Amendment is binding upon, and inures to the benefit of, the parties hereto and their respective successors and permitted assigns.

XII.Reservation of Rights; No Waiver of Defaults.  Lender hereby reserves all of its

5


rights and remedies under the Credit Agreement and the other Loan Documents in all respects and for all purposes in addition to all other rights and remedies available to it under applicable Law or in equity.  This Sixth Amendment is not intended to operate as a waiver of Lender’s rights and remedies and does not constitute or operate as (a) a waiver of (or a consent to) any existing Potential Default or Default or any other violation of or noncompliance with any provision of the Credit Agreement, as amended hereby, or any other Loan Document, (b) an agreement to waive any existing or future Potential Default or Default, or (c) a waiver of Lender’s right to insist upon strict compliance with each term, covenant, condition and provision of the Credit Agreement, as amended hereby, and the other Loan Documents.

XIII.ENTIRETY.  THIS SIXTH AMENDMENT REPRESENTS THE FINAL AGREEMENT AMONG BORROWER, GUARANTORS AND LENDER AND MAY NOT BE CONTRADICTED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS, OR SUBSEQUENT ORAL AGREEMENTS BY BORROWER, GUARANTORS AND LENDER.  THERE ARE NO UNWRITTEN ORAL AGREEMENTS AMONG BORROWER, GUARANTORS AND LENDER.

[Signature pages follow.]

6


IN WITNESS WHEREOF, the parties hereto have caused this Sixth Amendment to be duly executed on the Sixth Amendment Closing Date.

BORROWER:

IBIO CDMO LLC,

a Delaware limited liability company

By:

/s/ Felipe Duran

Felipe Duran

Authorized Person

Signature Page to Sixth Amendment to Credit Agreement


LENDER:

WOODFOREST NATIONAL BANK

By:

/s/ Cameron D. Jones

Cameron D. Jones

Senior Vice President

Signature Page to Sixth Amendment to Credit Agreement


GUARANTOR’S CONSENT AND AGREEMENT

As an inducement to Lender to execute, and in consideration of Lender’s execution of, this Sixth Amendment, IBIO, INC., a Delaware corporation (“Guarantor”), hereby consents to this Sixth Amendment, and agrees that this Sixth Amendment shall in no way release, diminish, impair, reduce or otherwise adversely affect the obligations and liabilities of the undersigned under the Guaranty executed November 1, 2021 (as amended by the Guaranty First Amendment, the Guaranty Second Amendment, the Guaranty Third Amendment, the Guaranty Fourth Amendment and as otherwise amended, restated, supplemented or modified from time to time, the “Guaranty”) executed by Guarantor in connection with the Credit Agreement.  Guarantor further represents and warrants to Lender that (a) the representations and warranties in the Guaranty are true and correct in all material respects on and as of the Sixth Amendment Closing Date as though made on such date (except to the extent that such representations and warranties specifically relate to an earlier date), (b) it is in full compliance with all covenants and agreements contained in the Guaranty, (c) after giving effect to the Sixth Amendment, no Potential Default or Default has occurred and is continuing under the Guaranty and (d) the execution and delivery of this Guarantor’s Consent and Agreement are within Guarantor’s power and have been duly authorized by all necessary company action.  This Guarantor’s Consent and Agreement shall be binding upon Guarantor, and its successors and permitted assigns, and shall inure to the benefit of Lender, and its successors and permitted assigns.

[Signature page follows.]


GUARANTOR:

IBIO, INC.,

a Delaware corporation

By:

/s/ Felipe Duran

Felipe Duran

Chief Financial Officer

Signature Page to Guarantor’s Consent and Agreement to
Sixth Amendment to Credit Agreement


Exhibit 99.1

PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

OF IBIO, INC. (UNAUDITED)

On September 15, 2023, iBio CDMO LLC, a wholly owned subsidiary of iBio, Inc, entered into a Purchase and Sale Agreement (the “Agreement”) with Majestic Realty Co. (“Majestic”) for the sale of its cGMP biologics manufacturing facility located in Bryan, TX (the “CDMO Facility”). The sale of the CDMO Facility will complete the divestiture of iBio’s contract development and manufacturing business in Texas, paving the way for the Company’s continued advancement of its AI drug discovery platform and immunotherapy pipeline out of its research and development center in California.

Under the terms of the Agreement, Majestic will purchase the approximately 130,000-square-foot CDMO Facility for $17,250,000. The net sales proceeds of the sale after paying all outstanding amounts on the Term Note with Woodforest National Bank (“Woodforest”) are expected to provide important non-dilutive funding to the Company.

The following Unaudited Pro Forma Consolidated Financial Statements have been prepared to comply with Article 11 of Regulation S-X, as promulgated under the Securities Act of 1933, as amended (“Regulation S-X”). The Unaudited Pro Forma Consolidated Balance Sheet at March 31, 2023, reflects the financial position of the Company as if the CDMO Facility sale occurred on March 31, 2023. The Unaudited Pro Forma Consolidated Statements of Income for the nine months ended March 31, 2023, and for the year ended June 30, 2022, present the Company’s results of operations as if the sale of the CDMO Facility was completed on July 1, 2022 and July 1, 2021, respectively. These Unaudited Pro Forma Consolidated Financial Statements should be read in conjunction with the accompanying notes to the unaudited pro forma financial statements; the Consolidated Financial Statements of the Company and the notes thereto and "Management's Discussion and Analysis of Financial Condition and Results of Operations" presented in the Company’s Quarterly Report on Form 10-Q for the nine months ended March 31, 2023, filed with the SEC on May 15, 2023 and the Company’s Annual Report on Form 10-K for the year ended June 30, 2022, filed with the SEC on October, 11, 2022.

The Unaudited Pro Forma Consolidated Financial Statements are not necessarily indicative of what the Company’s actual financial position or operating results would have been had the sale of the CDMO Facility occurred as of the dates indicated, nor are they indicative of future operating results of the Company. In the Company’s opinion, all adjustments necessary to reflect the effect of the sale of the CDMO Facility have been made.


Unaudited Pro Forma Consolidated Balance Sheet of iBio, Inc and Subsidiaries

As of March 31, 2023

(in thousands, except per share amounts)

    

    

Sale of

iBio Historical (A)

CDMO Facility

Pro Forma

Assets

Current assets:

Cash

$

6,562

$

5,011

  (B)  

$

11,573

Accounts receivable - trade

70

70

Subscription receivable

260

260

Convertible promissory note receivable and accrued interest

912

912

Prepaid expenses and other current assets

921

921

Current assets held for sale

18,368

(18,368)

(C)

Total current assets

27,093

(13,357)

13,736

Restricted cash

3,253

(3,000)

(D)

253

Convertible promissory note receivable and accrued interest

775

775

Finance lease right-of-use assets, net of accumulated amortization

678

678

Operating lease right-of-use asset

2,786

2,786

Fixed assets, net of accumulated depreciation

4,358

4,358

Intangible assets, net of accumulated amortization

5,393

5,393

Security deposits

50

(24)

(E)

26

Total Assets

$

44,386

$

(16,381)

$

28,005

Liabilities and Stockholders' Equity

Current liabilities:

Accounts payable

$

2,013

$

$

2,013

Accrued expenses

3,821

(285)

(F)

3,536

Finance lease obligation - current portion

265

265

Operating lease obligation - current portion

377

377

Equipment financing - current portion

156

156

Term note payable - ST - net of deferred financing costs

13,700

(13,700)

(G)

Current liabilities related to assets held for sale

1,944

(1,944)

(H)

Total Current Liabilities

22,276

(15,929)

6,347

Finance lease obligation - net of current portion

422

422

Operating lease obligation - net of current portion

3,225

3,225

Equipment financing - net of current portion

283

283

Accrued expenses - noncurrent

791

791

Total Liabilities

26,997

(15,929)

11,068

Equity

Series 2022 Convertible Preferred Stock - $0.001 par value; 1,000,000 shares authorized; 0 shares issued and outstanding as of March 31, 2023

Common Stock - $0.001 par value; 275,000,000 shares authorized at March 31, 2023; 15,818,149 shares issued and outstanding as of March 31, 2023

16

16

Additional paid-in capital

300,280

300,280

Accumulated deficit

(282,907)

(452)

(I)

(283,359)

Total Equity

17,389

(452)

16,937

Total Liabilities and Equity

$

44,386

$

(16,381)

$

28,005


NOTES TO THE UNAUDITED PRO FORMA

CONDENSED CONSOLIDATED BALANCE SHEET

(in thousands)

(A)

Reflects` the historical Consolidated Balance Sheet of the Company at March 31, 2023, as presented in the Company’s Q3 2023 10-Q.

(B)

Cash includes an increase in the cash amount of approximately $5,159 representing the estimated net proceeds received in connection with the sale of the CDMO facility after satisfying the debt with Woodforest Bank and estimated closing costs and the release of restricted cash held at Woodforest Bank. The net increase was reduced by $148 for real estate taxes owed, rent on land owed and amount owed for utilities.

(C)

Current assets held for sale represents the fair value of CDMO Facility and the operating lease right-of-use asset for the land on which the CDMO Facility is located.

(D)

The $3,000 held at Woodforest Bank in a restricted account will be released upon satisfaction of the mortgage.

(E)

This represents the return of a deposit from the utility company that services the CDMO Facility.

(F)

Includes real estate taxes, utilities, land rent and interest due to Woodforest Bank.

(G)

Gross debt related to the mortgage with Woodforest Bank on the CDMO Facility of $13,852 offset by $152 of deferred finance costs.

(H)

This amount represents the operating lease liability associated with the right-of-use asset for the land on which the CDMO Facility is located.

(I)

The presentation above assumes a $300 impairment on the CDMO Facility to write it down to its fair market value and $152 of expense related to the deferred finance costs.


iBio, Inc and Subsidiaries

Unaudited Pro Forma Consolidated Statements of Income For the Nine Months Ended March 31, 2023

(in thousands, except per share amounts)

    

    

Sale of

iBio Historical (A)

CDMO Facility

Pro Forma

Revenues

$

$

$

Operating expenses:

Research and development

7,971

7,971

General and administrative

16,407

16,407

Total operating expenses

24,378

24,378

Operating loss

(24,378)

(24,378)

Other income (expense):

Interest expense

(66)

(66)

Interest income

163

163

Loss on sale of debt securities

(98)

(98)

Total other (expense)

(1)

(1)

Net loss available to iBio, Inc. stockholders from continuing operations

(24,379)

(24,379)

Loss from discontinued operations

(34,598)

20,432

  (B)  

(14,166)

Net loss available to iBio, Inc. stockholders

$

(58,977)

$

20,432

$

(38,545)

Comprehensive loss:

Consolidated net loss

$

(58,977)

$

20,432

$

(38,545)

Other comprehensive income (loss) - unrealized gain (loss) on debt securities

180

180

Other comprehensive income - foreign currency adjustment

33

33

Comprehensive loss

$

(58,764)

$

20,432

$

(38,332)

Loss per common share attributable to iBio, Inc. stockholders - basic and diluted - continuing operations

$

(2.30)

$

$

(2.30)

Loss per common share attributable to iBio, Inc. stockholders - basic and diluted - discontinued operations

$

(3.27)

$

1.93

$

(1.34)

Loss per common share attributable to iBio, Inc. stockholders - basic and diluted - total

$

(5.57)

$

1.93

$

(3.64)

Weighted-average common shares outstanding - basic and diluted

10,592

10,592

10,592


NOTES TO THE UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENTS OF INCOME FOR THE NINE-MONTHS ENDED MARCH 31, 2023

(in thousands)

(A)

Reflects the historical Condensed Consolidated Statement of Income for the nine-months ended March 31, 2023.

(B)

Details of the CDMO discontinued operations shown above is as follow:

    

    

Sale of

CDMO Historical

CDMO Facility

Pro Forma

Revenues

$

391

$

$

391

Cost of goods sold

52

52

Gross profit

339

339

Operating expenses:

Research and development

6,361

6,361

General and administrative

6,165

(2,226)

  (C)  

3,939

Fixed asset impairments

17,600

(17,600)

(D)

Gain on sale of fixed assets

(732)

(732)

Inventory reserve

4,933

4,933

Total operating expenses

34,327

(19,826)

14,501

Other income (expenses):

Interest expense - term note payable

(606)

606

(E)

Other

(4)

(4)

Total other income (expenses)

(610)

606

(4)

Loss from discontinued operations

$

(34,598)

$

20,432

$

(14,166)

(C)

Represents facility and maintenance related expenses for the CDMO Facility, including employee related expenses, utilities, real estate taxes and depreciation on the building.

(D)

Represents the impairment adjustment recorded on the building to write down the carrying amount to its estimated fair value at March 31, 2023. Subsequently, an additional impairment of $300 was recorded and reflected in accumulated deficit on the March 31, 2023 Pro Forma Balance Sheet above.

(E)

Represents the interest expense on the mortgage on the CDMO Facility with Woodforest Bank.


iBio, Inc and Subsidiaries

Unaudited Pro Forma Consolidated Statements of Income For the Year Ended June 30, 2022

(in thousands, except per share amounts)

    

    

Sale of

    

iBio Historical (A)

CDMO Facility

Pro Forma

Revenues

$

1,884

$

$

1,884

Operating expenses:

Research and development

9,827

9,827

General and administrative

21,754

21,754

Total operating expenses

31,581

31,581

Operating loss

(29,697)

(29,697)

Other income:

Interest income

177

177

Royalty income

7

7

Total other income

184

184

Consolidated net loss from continuing operations

(29,513)

(29,513)

Net income attributable to noncontrolling interest

1

1

Net loss attributable to iBio, Inc. from continuing operations

(29,512)

(29,512)

Preferred stock dividends - iBio CDMO Tracking Stock

(88)

(88)

Net loss available to iBio, Inc. stockholders from continuing operations

(29,600)

(29,600)

Loss from discontinued operations

(20,791)

5,687

  (B)  

(15,104)

Net loss available to iBio, Inc. stockholders

$

(50,391)

$

5,687

$

(44,704)

Comprehensive loss:

Consolidated net loss

$

(50,304)

$

5,687

$

(44,704)

Other comprehensive income (loss) - unrealized gain (loss) on debt securities

(150)

(150)

Comprehensive loss

$

(50,454)

$

5,687

$

(44,854)

Loss per common share attributable to iBio, Inc. stockholders - basic and diluted - continuing operations

$

(3.39)

$

$

(3.39)

Loss per common share attributable to iBio, Inc. stockholders - basic and diluted - discontinued operations

$

(2.38)

$

0.65

$

(1.73)

Loss per common share attributable to iBio, Inc. stockholders - basic and diluted - total

$

(5.78)

$

0.65

$

(5.13)

Weighted-average common shares outstanding - basic and diluted

8,721

8,721

8,721


NOTES TO THE UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENTS OF INCOME FOR THE YEAR ENDED JUNE 30, 2022

(in thousands)

(A)

Reflects the historical Consolidated Statement of Income for the year ended June 30, 2022.

(B)

Details of the CDMO discontinued operations shown above is as follow:

    

    

Sale of

    

CDMO Historical

CDMO Facility

Pro Forma

Revenues

$

499

$

$

499

Cost of goods sold

216

216

Gross profit

283

283

Operating expenses:

Research and development

7,902

7,902

General and administrative

12,373

(4,275)

  (C)  

8,098

Total operating expenses

20,275

(4,275)

16,000

Other income (expenses):

Interest expense - term note payable

(602)

602

(D)

Interest expense - related party

(810)

810

(E)

Forgiveness of note payable and accrued interest - SBA loan

607

607

Other

6

6

Total other income (expenses)

(799)

1,412

613

Loss from discontinued operations

$

(20,791)

$

5,687

$

(15,104)

(C)

Represents facility and maintenance related expenses for the CDMO Facility, including employee related expenses, utilities, real estate taxes and depreciation on the building.

(D)

Represents the interest expense on the mortgage on the CDMO Facility with Woodforest Bank.

(E)

Represents the interest expense related to College Station Investors LLC, an affiliate of Bryan Capital Investors LLC, who prior to November 1, 2021, held a 0.01% interest in iBio CDMO. On November 1, 2021, iBio, Inc. acquired the 0.01% interest and iBio CDMO became a wholly owned subsidiary of iBio, Inc.


v3.23.3
Document And Entity Information
Sep. 15, 2023
Cover [Abstract]  
Document Type 8-K
Written Communications false
Document Period End Date Sep. 15, 2023
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Registrant Name iBio, Inc.
Entity Incorporation, State or Country Code DE
Securities Act File Number 001-35023
Entity Tax Identification Number 26-2797813
Entity Address, Address Line One 8800 HSC Parkway
Entity Address, City or Town Bryan
Entity Address, State or Province TX
Entity Address, Postal Zip Code 77807
City Area Code 979
Local Phone Number 446-0027
Title of 12(b) Security Common Stock
Trading Symbol IBIO
Security Exchange Name NYSEAMER
Entity Emerging Growth Company false
Entity Central Index Key 0001420720
Amendment Flag false
v3.23.3
N-2
Sep. 15, 2023
Cover [Abstract]  
Entity Central Index Key 0001420720
Amendment Flag false
Securities Act File Number 001-35023
Document Type 8-K
Entity Registrant Name iBio, Inc.
Entity Address, Address Line One 8800 HSC Parkway
Entity Address, City or Town Bryan
Entity Address, State or Province TX
Entity Address, Postal Zip Code 77807
City Area Code 979
Local Phone Number 446-0027
Entity Emerging Growth Company false

Grafico Azioni iBio (AMEX:IBIO)
Storico
Da Apr 2024 a Mag 2024 Clicca qui per i Grafici di iBio
Grafico Azioni iBio (AMEX:IBIO)
Storico
Da Mag 2023 a Mag 2024 Clicca qui per i Grafici di iBio